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1.1.  Cancer 
 
According to World Health Organization, cancer is one of the leading causes of death 
worldwide. In 2012 8.2 million people died due to cancer (WHO). More than 60% of the 
annual new cases occur in the underdeveloped and developing countries located in Africa, 
Asia, and South America. These countries bear more than 70% of the world's annual cancer 
deaths [1]. Uncontrolled proliferation of cells is called cancer. There are more than 200 types 
of cancer, but all of them results from the uncontrolled proliferation of abnormal cells. The 
unrepaired genetic aberrations often cause this abnormality. 
According to the American Cancer Society report (2014) on the history of cancer, cancer was 
described throughout the recorded history. The oldest description of cancer came from the 
Edwin Smith Papyrus dates back to 3000BC [3]. Edwin Smith Papyrus describes 8 cases to 
tumors of the breast that were removed by a fire drill. Cancers were also found in mummified 
humans of ancient Egypt. Hippocrates (460-370 BC), who is considered as the Father of 
Medicine used the terms carcinos and carcinoma (Greek meaning crab) to describe tumors 
due to the finger-like projections observed in cancer tumors. Later, a Roman physician, 
Celsus (28-50 BC), translated the Greek term into Latin cancer (Latin meaning crab). 
Another Greek physician Galen (130-200 AD) used the term oncos (Greek meaning swelling) 
to describe tumors [4,5]. This term is now used to represent the study of cancer - oncology 
and to the people who study cancer – oncologists. In 1761, Giovanni Morgagni of Padua did 
autopsies to relate the patient’s illness to pathologic findings, which laid the foundation for 
the scientific study of cancer [4]. Scottish surgeon John Hunter (1728-1793) made a 
statement that cancer can be cured by surgery. Rudolf Virchow, who is credited as the 
founder of cellular pathology, provided the scientific basis for the pathology of cancer. 
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1.2.  Causes of cancer: 
The pursuit for the identification of causes of cancer can be found as early as ancient 
Egyptians, who blamed cancers on gods. Hippocrates proposed the humoral theory, which 
states that there are four humors (body fluids) namely blood, phlegm, yellow bile and black 
bile. The key idea is that any imbalances in these four humors caused diseases. Cancers were 
believed to be caused by the excess of black bile. This theory was accepted and even taught 
by Galen. This theory remained unchallenged for over 1300 years. Lymph theory is one of 
the theories that replaced humoral theory. Stahl and Hoffman proposed that cancer was 
composed of fermenting and degenerating lymph that are varying in density, acidity and 
alkalinity. This theory was supported by John Hunter. In 1838, German pathologist Johannes 
Muller came to the conclusion that the cancer is made up of cells and lymph. However, he 
did not believe that cancer arose from the healthy cells and proposed that cancer developed 
from the budding elements called blastemal and existed between the normal tissues. This 
theory was proved wrong by Muller's student Rudolph Virchow, who demonstrated that all 
cells including cancer arise from other cells. Rudolph Virchow came up with the chronic 
irritation theory, where he theorized that cancer is caused by the chronic irritation but 
incorrectly conceived that cancer spread like liquid. In the 1860s, German surgeon Karl 
Thiersch disproved the liquid like spread notion of Virchow by showing that cancers spreads 
through malignant cells and not via a fluid. Trauma was also believed to be the cause of 
cancer from the late 1800s to 1920s. Two Holland doctors, Zacutus Lusitani (1575-1642) and 
Nicholas Tulp (1593-1674) proposed the contagion theory in 1649 and 1652 respectively 
based on their encounters with breast cancer in members of the same household [4,5]. They 
suggested that cancer is an infectious disease and cancer patients should be isolated. Now it 
has been proven that human cancer is not contagious but certain viruses, bacteria and 
parasites can make a person susceptible to develop cancer [2]. 
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In 1761, London clinician John Hill recognized tobacco as a carcinogen, a substance that 
causes cancer. Tobacco has been rediscovered as the most lethal chemical carcinogen known. 
In 1915, Katsusaburo Yamagiwa and Koichi Ichikawa at Tokyo University induced cancer in 
rabbit by applying coal tar on its skin. Ionizing radiations from a variety of sources including 
the sun has to be proven to cause cancer [6]. In 1775, Percival Pott of Saint Bartholomew's 
Hospital in London observed occupational cancer of the scrotum in the people whose 
occupation is sweeping the chimney. He identified that this cancer is caused by the soot that 
is collected in the skin fold of the scrotum [6]. This study led to the public health measures to 
reduce the cancer risk at work by identifying and avoiding potential carcinogens in the work 
environment. 
In 1911, Peyton Rous, at the Rockefeller Institute, described sarcoma in chickens for the first 
time, which eventually became Rous sarcoma virus and earned him a Nobel prize in 1968. 
Now we know several viruses that can cause cancer. Chronic infection with hepatitis B or C 
viruses can lead to liver cancer. Epstein-Barr virus had been linked with non-Hodgkins 
lymphomas and nasopharyngeal cancer. HIV (Human Immunodeficiency Virus) infection 
could increase the risk of developing various cancers, especially Kaposi sarcoma and non-
Hodgkin lymphoma. Human Papillomavirus (HPVs) infection increases the cancer risk 
especially cancers of the cervix, vulva, vagina, anus, and pelvis. HPV infection can be 
prevented by vaccination [2,6]. 
The International Agency for Research on Cancer (IARC) has identified more than 100 
chemicals, physical and biological carcinogens. Understanding of DNA and genes lead to the 
notion that DNA damage due to the chemicals and radiations, or introduction of new DNA 
sequences by viruses causes cancer. The cells with damaged DNA (mutated DNA) lead to the 
clones of abnormal cells. These abnormal clones become malignant clones by acquiring more 
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mutations. The fundamental difference between the normal tissues and cancer is that normal 
cells with damaged DNA dies but the cancer cells with damaged DNA do not die. 
The 1970s saw the dramatic breakthrough in the cancer research. Researchers discovered two 
families of genes related to cancer: oncogenes and tumor suppressor genes. Oncogenes are 
responsible for the uncontrolled proliferation of cells. They arise from the mutations of the 
normal genes that control the cell division called proto-oncogenes. Tumor suppressor genes 
are involved in inhibiting the cell division, repair damaged DNA sequences and induce 
apoptosis (programmed cell death). Mutations in these genes could lead to uncontrolled 
proliferation of cells resulting in cancer. Inheritance of these mutated genes can cause cancer 
to the progeny [2,6]. 
1.3. Methods of cancer diagnosis:    
Diagnosis of cancer at an early stage can prevent many cancer deaths. These data suggest that 
the people belong to the underdeveloped and developing nations, who did not have proper 
awareness and medical care is the worst hit by cancer. As the current cancer diagnostic 
procedures were laborious and expensive, many people around the world could not afford 




Data Source: WHO 
Figure 1.1: Mortality rate of cancer in the world. Mortality rate = (total number of cancer 
deaths/ total number cancer cases reported) *100. 
 
Current methods of cancer detection include computed tomography (CT) scans, 
mammograms, Pap (Papanicolaou test) and HPV testing, prostate specific antigen (PSA) 
tests, sentinel lymph node biopsy, tumor markers screening, endoscopy and other laboratory 
tests.  CT scans are useful in screening lung cancer and colorectal cancer. CT scans are used 


















































































































































































treatment. Despite these advantages, CT scan works on passing the ionizing radiation into the 
body, which increases the risk of cancer, in particular for children. The risk of leukemia, 
brain cancer, and other cancers is very high for the children, who have undergone multiple 
CT scans below 15 years of age [7,8].  
Mammography diagnosis cancer in the breast by using X-ray imaging technique. There are 
two types of mammograms: screening mammograms and diagnostic mammogram. Screening 
mammograms help to prevent breast cancer deaths by early detection. Diagnostic 
mammograms need a longer period of X-ray exposure, which is potentially undesired. Apart 
from the radiation exposure, the major limitations of screening mammography are high false 
positives and false negative results.   
Pap and HPV testing are performed for the detection of cervical cancer in females. This test 
is based on the fact that, almost all types of cervical cancers are caused by the oncogenic 
human papillomavirus infection. Pap test is the cytological examination of the cells taken 
from the cervix for the detection of the abnormal cells. HPV test involves the detection of 
HPV DNA in the cervical swab samples. These cervical swabs were tested for the presence 
of the HPV 16 and HPV 18 DNA as these two types are highly dangerous in causing cervical 
cancer. Once this test is positive, it is followed by the further test for the detection of the 
HPV RNA.  Although, Pap test and HPV test is less invasive; it is very discomfort for the 
patients.  
PSA test is carried out for diagnosing prostate cancer. PSA is a protein produced by the 
prostate cancer cells, whose concentration in blood tends to increase. PSA test can be false 
positive or false negative as the there are many cases reported that men could have increased 
PSA level in the absence of prostate cancer and also not all prostate cancers are correlated 
with the increase in the PSA level in blood. It is noteworthy that prostate cancer can also be 
diagnosed by transrectal biopsy or transperineal biopsy followed by microscopic 
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examination. But this procedure is invasive and discomfort for the patient. Biopsy and 
biomarker identification is the gold standard method of diagnosis for most cancers. 
1.4.  Melanoma: 
1.4.1. Causes of Melanoma: 
This thesis focuses on two types of cancers namely melanoma and gastric cancer. 
According to the National Cancer Institute, melanoma is a type of skin cancer, arise from 
melanocytes. The common risks of developing skin cancers include over exposure to 
sunlight. Sunlight is a major source of UV radiation. People who experienced blistering 
sunburn at least once and people sensitive to sun burn have increased the risk of developing 
any skin cancer including melanoma. The artificial sources of UV radiations including 
sunlamps and tanning booths cause severe DNA damage to the skin cells leading to cancer. 
People with fair skin have higher chances of developing skin cancers. Melanoma is very rare 
in people with dark skin. Other risk factors include dysplastic nevus, which is a type of mole, 
bigger than the normal mole. Its surface is smooth, scaly or pebbly with irregular borders. 
Dysplastic nevus has high chances of turning into a melanoma than an ordinary mole [9]. 
1.4.2. Diagnosing Melanoma: 
The first sign of melanoma is the change in the shape, color, and size of the existing mole. 
Melanoma can be identified by looking for the few features abbreviated as "ABCDE." ‘A’ 
stands for the existence of asymmetry in the shape of the mole. ‘B’ stands for the irregular 
borders. ‘C’ stands for the uneven color complexion of the mole. ‘D’ stands for the increase 
in the diameter of the existing mole and finally ‘E’ stands for the continuous evolution of the 
mole over few weeks or months. The melanoma can be identified by closely looking for these 
“ABCDE” in the existing moles. The current standard for the diagnosis of melanoma is 
biopsy followed by the pathological examination. Excisional biopsy was performed for 
melanoma diagnosis, where the doctor excises the entire suspected growth along with some 
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tissues around it [9]. Especially for the melanoma, the doctor checks lymph nodes around the 
suspected region. If the lymph nodes are observed to be enlarged, the cells from the lymph 
node were removed using fine-needle aspiration biopsy and sent for the pathological 
examination. This method will help to identify whether the melanoma had already undergone 
metastases. If the melanoma is thick, the surgeons perform sentinel lymph node biopsy to 
remove the entire lymph node. This procedure is done because cancer cell tends to appear 
first in the sentinel lymph node before spreading to other lymph nodes [9].   
1.5.  Gastric Cancer: 
1.5.1. Gastric Cancer and its Types: 
Gastric cancer ranks third in the mortality rate (723,000 deaths/year) worldwide next to lung 
cancer (1.59 million deaths/year) and liver cancer (745 000 deaths/year) [1]. According to the 
American Cancer Society’s report on stomach cancer (2014), stomach cancer is also known 
as gastric cancer, which is cancer arises from the stomach. Gastric cancers are slow growing 
cancer. Gastric cancer usually starts as a precancerous lesion in the inner lining (mucosa) of 
the stomach. These precancerous lesions were very hard to detect and often went undetected 
[10]. Gastric cancer can be categorized into different types as follows: adenocarcinoma, 
lymphoma, gastrointestinal stromal tumor (GIST), carcinoid tumor and other rare cancers like 
squamous cell carcinoma, small cell carcinoma, leiomyosarcoma, etc.   Adenocarcinoma is 
the major type of gastric cancer; about 90-95% of gastric cancers were adenocarcinomas. 
These cancers arise from the mucosal cells. About 4% of gastric cancers are lymphomas. 
These are the cancers of immune system found in the wall of the stomach. GIST is a rare 
form of gastric cancer arising from the interstitial cells of Cajal. Carcinoid tumors arise from 
the hormone synthesizing cells of the stomach. About 3% of the gastric cancers are carcinoid 
tumors. Stomach cancer mostly affects the older adults, whereby the average age for 
developing gastric cancer is 69 years. About 6 of the ten people diagnosed with gastric cancer 
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were aged more than 65 years. Today, gastric cancer incidence is high in the less developed 
countries, where gastric cancer is the leading cause of cancer-related deaths [11]. 
1.5.2. Symptoms of Gastric Cancer: 
In countries like Japan, which tops the gastric cancer incidence subject their people for the 
mass screening for gastric cancer. This mass screening initiative helped in identifying many 
people who were at the early or curable stages of gastric cancer reducing the gastric cancer 
deaths, but this is yet to be proved. Screening for gastric cancer is usually not done until the 
person experiences certain signs and symptoms of gastric cancer. Unfortunately, early stages 
of gastric cancer do not cause any symptoms, which is the principal bottleneck in detecting 
gastric cancer at early stages. The symptoms of gastric cancer include poor appetite, 
unexplainable weight loss, abdominal pain, discomfort in the abdominal region above the 
navel, a sense of fullness in the upper abdomen even after a small meal, indigestion or 
heartburn, nausea, vomiting with or without blood, swelling in the abdomen, anemia, etc. 
Since the symptoms of gastric are not caused by the advanced stages, only about 20% of the 
gastric cancers were diagnosed before metastasis in the USA. This discrepancy is the reason 
behind the high mortality rate of gastric cancer throughout the globe [10].  
1.5.3. Diagnosing Gastric cancer: 
If a person exhibits vague symptoms, such as indigestion, weight loss, nausea, and loss of 
appetite, screening tests may be recommended. Stomach cancer can be detected by various 
methods but the most commonly used methods or the following. 
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Data Source: WHO 
Figure 1.2: Mortality rate of gastric cancer in the world. Mortality rate = (total number of 
gastric cancer deaths/ total number gastric cancer cases reported) *100. 
 
1.5.3.1. Esophagogastroduodenoscopy and biopsy:  
This test examines the esophagus and stomach using a thin, lighted tube called a gastroscope, 
which is passed through the mouth into the stomach. Through the gastroscope, the doctor can 
look directly at the inside of the stomach. If an abnormal area known as linitis plastica is 
found, the doctor will remove some tissue (biopsy) to be examined under a microscope. A 
biopsy is the only sure way to diagnose cancer. Gastroscopy and biopsy are the best methods 
of identifying stomach cancer. Hence this approach is the current gold standard method for 
the diagnosis of the stomach cancer. Even though this method, have high specificity and 





















an invasive procedure with potential complications such as perforation and aspiration and is 
not a cost-effective screening tool for most of the countries. Unfortunately, stomach cancers 
in hereditary diffuse gastric cancer syndrome cannot be detected in endoscopy [10].  
Endoscopy can also be used as part of an imaging test for gastric cancer, known as 
endoscopic ultrasound. In this method, a small transducer is placed at the tip of the 
endoscope. The patient needs to be sedated before this test. After sedation, the endoscope is 
passed into the stomach via throat. This procedure allows the doctor to visually access the 
spread of cancer in the stomach wall as well as the nearby lymph nodes. This approach also 
helps to guide the needle biopsy. Once the biopsy is taken it is sent to the pathologist, who 
observes the biopsies under microscope and look for the histological features of cancer. If the 
biopsy contains cancer cells, then the pathologist finds out the type of gastric cancer. If the 
sample is identified as adenocarcinoma, then it will be tested for the over-expression of the 
growth-promoting protein called HER2/neu. If it is positive, then these tumors are 
categorized as HER2 positive adenocarcinoma and treated accordingly [12]. 
1.5.3.2. Upper gastrointestinal (GI) series: 
There are many imaging tests available for diagnosing gastric cancers which use different 
modalities like x-rays, magnetic fields, sound waves or radioactive substances. One such test 
is the upper gastrointestinal (GI) series. For this test, the patient is required to take barium as 
contrasting agent. The ingested barium coats the gastrointestinal wall. As X-rays cannot pass 
through the barium, the obtained X-ray pictures clearly show the abnormalities in the 
gastrointestinal wall. The main drawback of this method is the inability to get biopsies [10].  
1.5.3.3. Computed Tomography (CT) scan:  
Another X-ray based imaging test for gastric cancer is computed tomography scan (CT). For 
this test, the patients receive a contrast dye through intravenous injection line followed by the 
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CT scanning, which clearly confirms the location of cancer and also the spread of cancer. In 
this imaging modality, the contrast dye is not suitable for everyone. Although fatal 
complications are rare, a significant proportion of the people is allergic to this contrast dye 
[10].   
1.5.3.4. Magnetic resonance imaging (MRI) scan:  
Magnetic resonance imaging (MRI) scan is another imaging modality where radio waves 
were used instead of X-rays. The applied radio waves under a strong magnetic field are 
absorbed and released by the body parts, which is translated into detailed image of the body 
parts using a computer aided processing algorithm. MRI scans take longer time to scan when 
compared to other imaging modalities. Thus the patient has to lie in a narrow tube for more 
than an hour, which is very uncomfortable for the older adults [10]. 
1.5.3.5. Positron emission tomography (PET) scan:  
Another imaging modality is the positron emission tomography (PET) scan, where 
radioactivity is employed to image cancer. A low dose of glucose-related radioactive 
substance called FDG is injected into the veins of the patient. As cancer cells consume sugar 
more than the normal cells, cancer cells tend to accumulate this radioactive glucose analog. 
Images from the PET scanner give the location and spread of cancer. This imaging modality 
is very useful to identify the location of the metastatic cancers as they scan for the 
radioactivity in the whole body. PET/CT hybrid scanners are available in the market and this 
hybrid machines are highly suitable for imaging gastric cancer. However, this procedure is 
expensive and not suitable for everyone [10]. 
1.5.3.6. Recent advances in gastric cancer biomarker identification:  
Recently, certain serum biomarkers were identified for the diagnosis of gastric cancer, but 
these serum biomarkers were low in specificity and sensitivity. Chen et al. identified the 
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differential expression of certain metabolites by gas chromatography and mass spectrometry 
of the tumors isolated from the xenografted severe combined immunodeficiency (SCID) 
mice. They found 29 metabolites that are differentially expressed between the metastatic and 
non-metastatic gastric cancer tumors. Among which 20 are up-regulated, and nine are down-
regulated [13]. Hao et al. isolated gastric cancer tissues and matched normal tissues from the 
18 gastric cancer patients and identified 18 metabolites that are differentially expressed 
between cancerous and non-cancerous tissues using gas chromatography and mass 
spectrometry. These studies involve the identification of the metabolic biomarkers of the 
cancer tissues that needs the isolation of the cancer tissue that is invasive [14]. Jun et al. 
identified the differential expression of 10 metabolites between cancerous and non-cancerous 
group and seven metabolites between the metastatic and non-metastatic group by gas 
chromatography and mass spectrometry of the urine from the xenografted SCID (Severe 
combined immunodeficiency) mice [15]. However, the metabolic biomarkers identified were 
not- specific.  Hence it is imperative to develop an inexpensive, easy to operate and non-
invasive diagnostic tool for the diagnosis of gastric cancer. 
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Figure 1.3. Illustration of Esophagogastroduodenoscopy  
(Source: http://gisantamaria.com/egd/) 
1.6. Metabolomics: 
The metabolome is the ensemble of all the small molecules present in the cells, tissues, 
organs and biological fluids. The study of metabolome at global level is called metabolomics. 
Gene expression, protein expression, and the environmental cues play a vital role in 
synthesis, concentration, and flux of these metabolites. Any disease or syndrome can be 
traced back to any one or combination of the factors as mentioned above namely gene 
expression, protein expression, and environmental cues. Thus metabolite by itself or its 
concentration or its flux would be unique to the different pathological state. Hence 
metabolites could provide us the relevant information about the diseases and syndromes. In 
other words, metabolites could serve as the potential disease markers for the disease 
diagnosis. 
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The metabolites of the cells are known as cellular metabolites. Cellular metabolites can be 
grouped into three types as follows: (1) intracellular metabolites, (2) volatile metabolites and 
(3) surface metabolites. Intracellular metabolites are the metabolites that are synthesized or 
consumed by the cell and that are located within the cells. Volatile metabolites are the 
volatile organic compounds that are released by the cells into the environment as a product of 
metabolism. Surface metabolites are metabolites that are located on the surfaces or cell 
membrane. Intracellular metabolites can serve as potential biomarkers but for the detection of 
these biomarkers need invasive procedures like endoscopy. The intention of our study is to 
develop novel non-invasive biomarkers. Hence we concentrate on the volatile metabolites 
and cell surface metabolites, which are promising for the development of non-invasive 
biomarkers. 
1.6.1. Volatile Metabolites: 
Volatile organic compounds present in a person's exhaled breath can be an indicator of the 
pathological status of that person. The Roman physicians used the smell of the patient's 
breath for diagnosing the diseases. Some of the breath biomarkers used to them were as 
follows: sweet, acetone smell was used as an indicator for diabetes, liver failure was 
identified using the fish like smell, and renal failure is detected using the urine smell [16]. 
Hippocrates of Kos (460–370 BC) first described fetor oris and fetor hepaticus in his treatise 
on breath aroma and disease. In 1782-83, Antoine Lavoisier detected carbon dioxide (CO2) 
in the exhaled breath of guinea pigs, interpreted this as a product of combustion and paved 
the way for using CO2 as a sign of life with its ubiquitous clinical use today [17]. In 1898, 
Johannes Müller performed the first quantitative investigations of acetone in exhaled breath 
[18]. Pauling, a noble laureate commenced the hunt for the volatile compounds in the breath. 
He could able to measure over 250 compounds in the human breath in 1971 by using Gas 
chromatography [19].  In 1999 Phillips estimated over 3000 compounds in the human breath. 
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Breath test for volatile markers of oxidative stress appeared to provide a sensitive and 
specific set of biomarkers for breast cancer [20]. Breath VOCs contained apparent 
biomarkers of active pulmonary tuberculosis comprising oxidative stress products (alkanes 
and alkane derivatives) and volatile metabolites of M. tuberculosis (cyclohexane and benzene 
derivatives) [21]. 
Exhaled breath contains thousands of volatile organic compounds (VOCs) of which the 
composition varies depending on health status (Table 1.1 and Table 1.2). Various metabolic 
processes within the body produce volatile products that are released into the blood and will 
be passed on to the airway once the blood reaches the lungs. Moreover, the occurrence of 
chronic inflammation and oxidative stress can result in the excretion of volatile compounds 
that generate unique VOC patterns [22]. 
S. No Condition Breath Markers 
1 Lipid peroxidation Alkanes and aldehydes. 
2 Diabetes Acetone, propan-2-ol and methyl nitrate. 
3 Cancer Alkanes, methylated alkanes, aromatic 
compounds, and aldehydes. 
4 Heart transplant rejection Alkanes and methylated alkanes. 
5 Lung transplant rejection Carbonyl sulfide. 
6 Airway inflammation Nitric oxide and halogenated amines. 
7 Cholesterol-lowering therapy Isoprene. 
8 Liver disease Sulfur compounds, carboxylic acids, 
ammonia, and ketones. 
9 Kidney disease Dimethylamine, trimethylamine, and 
ammonia. 
10 Oral malodour Sulfur compounds. 
11 Trimethylaminuria Trimethylamine. 
12 Congestive heart failure Acetone. 






S. No. Volatile organic compounds Probable origin 
1 Acetone Fatty acid metabolism 
2 Isoprene Cholesterol synthesis 
3 Methanol Dietary sources 
4 Propanol Acetone metabolism 
5 Acetaldehyde Ethanol metabolism 
6 Ammonia Protein metabolism 
7 Dimethyl sulphide Methionine metabolism 
8 Dimethyl disulphide Methionine metabolism 
9 Hydrogen sulphide Methionine metabolism 
10 Ethane Lipid peroxidation 
11 Ethene Lipid peroxidation 
12 Pentane Lipid peroxidation 
13 C1-C5 alkanes Colonic bacteria 
14 C1-C5 alcohols Colonic bacteria 
15 C1-C5 carboxylic acids Colonic bacteria 
Table 1.2: List of VOCs and their probable endogenous origin.  
The compounds in the exhaled breath can be classified into three categories: 
1. Inorganic compounds: this group includes carbon dioxide, oxygen, and nitric acid. 
2. Non-volatile compounds: this category includes compounds like cytokines, 
leukotrienes, hydrogen peroxide, and isoprotanes. 
3. Volatile organic compounds (VOC): this category is the largest of the three and 
contains organic compounds of different classes such as saturated hydrocarbons like 
ethane, pentane, aldehydes, etc., unsaturated hydrocarbons like isoprene, oxygen-
containing organic compounds like acetone, sulfur-containing organic compounds 
like ethyl mercaptan, dimethyl sulfide, etc., nitrogen-containing organic compounds 
like dimethyl amine, ammonia, etc. The most commonly detected VOCs in the breath 
are isoprene, alcohols, and alkanes. 
The VOC category is an important group of volatile compounds in this context. The 
VOCs of exhaled breath can be produced endogenously or exogenously.  Endogenous in 
a sense as the end products of metabolic pathways for example isoprene, an unsaturated 
hydrocarbon formed during the mevalonic acid pathway of cholesterol synthesis, acetone 
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formed from the glucose metabolism and alkanes formed by the oxygen free radical-
mediated lipid peroxidation in the cell membranes. Hence, alkanes are the key biomarkers 
of the oxidative stress. Exogenously the VOCs can be contaminants that are inhaled from 
the environment [23].  
The relationship between volatile organic compounds (VOCs) in exhaled breath and local 
or general pathologies is a most exciting field of research. Different chemical signatures 
have been observed in breath from patients with lung, cardiovascular, gastrointestinal, 
liver, renal or mental diseases, diabetes, and different types of cancer or physiological 
conditions such as pregnancy. Prior studies suggest that depending on the affected tissue 
or organ, volatiles can have a specific profile. However, to date, information on the 
biochemical origin of this volatiles is rare [24].  
1.7. Proton Nuclear Magnetic Resonance (NMR) Spectrometry: 
 Three instruments were used in these studies; they are proton nuclear magnetic 
spectrometry (NMR), Gas chromatography and mass spectrometry (GC-MS) and selected 
ion flow tube mass spectrometry (SPME-MS).  Nuclear magnetic resonance (NMR) 
spectrometry identifies a unique chemical shift biomarker 1.28 ppm for the identification 
of the neural stem and progenitor cells (NPC). They could even identify the NPC in live 
mouse using this biomarker under proton magnetic resonance spectroscopy (1H-MRS). 
This achievement is possible as each type of cells has their unique surface receptor 
proteins and phospholipid composition. This study motivates us to look for the NMR-
based biomarkers for melanoma and gastric cancer. 
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Nuclei are positively charged dense region located at the center of an atom. Nuclei tend to 
spin on an axis, which creates a small magnetic field and magnetic moment (µ).
 
        γ - gyromagnetic ratio (1H = 26,752) 
       h – Planck’s constant 
In the native state, the tiny magnetic fields around the nuclei are randomly oriented. But 
under the external applied magnetic field (B0), these magnetic fields will either align or 
oppose the applied magnetic field. The energy difference between the aligned and 
opposed nuclear magnetic fields is small and depends on B0. 
∆" = ℎ% 
∆" = 	'ℎ()2+  
When the radio waves are applied to the nuclei under applied magnetic field, the nuclear 
spin-flip their orientation and the nuclei is said to be in resonance with B0. Different 
nuclei absorb radio waves at different wavelength. Nuclei will resonate at different 
energies depending on their chemical and electronic environment. This resonance forms 
the NMR signals; the position referred as chemical shift and pattern called splitting, or 
multiplicity gives the information about the chemical environment of the nuclei [25]. 
The NMR machine has a provision for the placing the NMR sampling tubes containing 
the sample of interest. This arrangement is surrounded by a strong magnet and coils for 
applying radio waves. The strong magnetic field is first applied to the samples, which will 
align the nuclei in the samples to align or oppose the applied magnetic field 
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instantaneously. Then the radio frequency is passed to the samples at different 
wavelengths, and corresponding NMR signals will be acquired using a computer software 
application.  
     
Figure 1.4: Working of Nuclear Magnetic Resonance Spectrometry. (Source: 
http://www.agilent.com/labs/images/figure2.jpg) 
 
1.8.  Solid-phase Microextraction and Gas Chromatography-Mass 
Spectrometry (SPME-GCMS):  
Gas chromatography coupled with mass spectrometry is considered as the gold standard 
method for analyzing volatile organic compounds. The gas chromatography was invented 
by Martin and James in 1952 [26]. In GC, the sample to be analyzed is introduced to very 
high temperature (200-300° C) and mixed with a stream of carrier gas which is helium 
(He). This mixture is subsequently entered the chromatographic column made up of fused 
silica tubular capillary coated internally with a thin polymer film. Depending on the 
chemical structure, the analyte molecules are partitioned between the carrier gas stream 
(mobile phase) and the polymer coating (stationary phase). When the partitioned analyte 
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molecules reach the end of the stationary phase, they move to the detection system based 
on the thermal conductivity, ionization in a flame or electron capture is employed to 
produce an electrical signal that is proportional to the concentration of the analyte 
molecules. These electrical signals are plotted against time resulting in a gas 
chromatogram. The mass spectrometer is used to identify the compounds that were 
causing the electrical signals. The mass spectrometer generates a fingerprint of the 
compound using the charged fragments generated as a result of dissociation. This mass 
fingerprint is known as mass spectrum based on which the compounds can be identified. 
The GC-MS analysis gives retention times, chromatographic areas and mass spectra of 
each compound in a mixture that is obtained as a result of ionization of electron impact at 
standard energy of 70 eV. 
 
       Figure 1.5: Working of Gas Chromatography and Mass Spectrometry (Source: Kim, I., Suh, 
S., Lee, I., & Wolfe, R. R. (2016). Applications of stable, nonradioactive isotope tracers in 
vivo human metabolic research. Experimental & Molecular Medicine, 48(12). 
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Even though GCMS is a very traditional method for the VOCs analysis, this approach has 
certain weakness such as matrix effects. It requires accurate sample preparation before the 
actual analysis. It is not real time and needs 10-60 mins to analyze single sample. Thus 
limiting its use in the researches where a large number of samples to be analyzed on the 
same day. Pre-concentration of the samples is a must for the biological specimens, and it 
is mostly done using solid phase micro-extraction procedure (SPME) followed by thermal 
desorption (TD) before GC [27].  SPME is a very successful solvent free method of 
sample preparation for GC. It was invented by Pawliszyn et al. in 1989. It is a simple 
device looks like a syringe consisting a fiber holder which is needle and a fiber assembly. 
This fiber is made up of fused silica optical fiber coated with the VOC adsorbing polymer 
film such as polydimethylsiloxane (PDMS), carbowax, etc. This polymer coating adsorbs 
the VOCs when exposed to the environment which is known as headspace sampling. 
Once the sampling is done the fiber is retracted into the fiber holder and transferred to the 
inject port of the GC which is at 250-280° C. when the fiber is exposed to the injection 
port, the VOCs adsorbed to the fiber will be desorbed due to the high temperature of the 
port [28]. This procedure is called thermal desorption (TD).  
1.9.  Selected Ion Flow-Tube Mass Spectrometry: 
 




The SIFT-MS is derived from the selected ion flow tube (SIFT) method developed by N.G. 
Adams and D. Smith in 1976 [29]. It was initially developed for studying the kinetics of gas 
phase reactions between ions and molecules. Later in 1995, D.Smith and P. Spanel developed 
SIFT-MS method for the analysis of trace gases. In 1997, transportable SIFT was constructed 
at Keele University, and the current portable version of SIFT-MS was built in 2006. The 
principle of SIFT-MS is the chemical ionization, where the neutral molecules were ionized 
using the selected precursor ions. Chemical ionization minimizes the number of fragmented 
product ions, thus simplifying the resulting mass spectrum [30]. In this dissertation, the 
precursor ions were used namely H3O+, NO+ and O2+. These three precursor ions are ideal as 
they unreactive to the major components of the ambient air, thus facilitating the analysis of 
the trace compounds [31-33]. This multiple precursor ion strategy is the real strength of 
SIFT-MS method. 
The precursor ions are generated in a microwave glow discharge ion source from a mixture of 
steam and air, maintained at 0.3 mbar [34]. From these generated ions, the selected precursor 
ions were filtered out by a mass filter. A current of these selected precursor ions is injected 
into a fast flowing helium carrier gas. These precursor ions along with the carrier gas enter 
the flow tube, where the sample to be analyzed is introduced. The volume of the sample 
injected can be controlled using the flow meter connected to the sampling inlet. The 
precursor ions react with the gases in the injected sample. Theses reactions resulted in the 
generation of the product ions. These product ions where detect and identified using the 
quadrupole mass spectrometer and counted by the channeltron multiplier/pulse counting 
system. The computer software application generates an output plot of product ion M/Z ratios 
vs. counts per second (C/S). SIFT-MS can be operated in two modes: 1. Full scan mode (FS) 
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and 2. Multiple ion monitoring mode (MIM) [35].  In FS mode the mass spectrum of all the 
product ion M/Z within the selected range will be detected. This method is particularly useful 
when there is no information about the sample is known. In MIM mode only the count rates 
of the selected product ions were monitored. This mode is used to quantify the VOCs that are 
known to present in the sample. In this dissertation, FS mode is used as there is no prior 
information is available regarding the composition of the VOCs in our samples. 
1.10. Thesis objectives: 
The primary objectives of this thesis is as follows: 
1. To explore the possible ways of identifying non-invasive biomarkers for cancers. 
2. To identify and confirm the reliability of the non-invasive cancer biomarkers using in-
vitro 3D cancer models. 
3. To carry out a clinical study focused on discovering novel non-invasive cancer 
biomarkers. 
4. To develop a low-cost, reusable, portable, easy to operate and novel diagnostic tool 
for detecting the non-invasive cancer biomarkers identified in the clinical study. 
 

























Proton NMR characterization of intact primary and metastatic 
melanoma cells in 2D & 3D cultures 
 
2.1. Background:  
14.1 million new cancer cases are reported every year with 8.2 million annual deaths [1]. As 
cancer is very heterogeneous, it is indispensable to have a better characterization procedure 
for its diagnosis and treatment. One non-destructive way of characterizing cancer cells is by 
employing nuclear magnetic resonance. In this study, we intend to access the specificity of 
the proton NMR method using the two closely associated melanoma cell lines. Cancer cells 
contain higher levels of phospholipids than normal cells, which was responsible for enhanced 
cell proliferation and signal transduction. The alteration of phospholipid composition aids the 
cancer cells in the invasion, metastasis, and expression of growth factor receptors [36,37]. 
Past studies concluded that 1H MRS could be used to diagnose cancer and also to monitor 
treatment responses [38-41]. It had been reported in the gene expression studies that 576 
genes were differentially expressed between primary melanoma and metastatic melanoma 
among which most of the genes showed decreased expression in metastatic melanoma when 
compared to primary melanoma [42]. These genes were found to be involved in cell 
adhesion, tumor suppression, cell cycle regulation and apoptosis. It is noteworthy that two 
proteins namely MAGEC1 (Melanoma antigen family c1) and FCRL1 (Fc receptor-like 1), 
which were known for melanoma progression were up-regulated in metastatic melanoma 
[42]. Another study showed that in primary melanoma SPRR1A/B, KRT16/17, CD24, LOR, 
GATA3, MUC15, and TMPRSS4 were up-regulated whereas, MAGE, GPR19, BCL2A1, 
MMP14, SOX5, BUB1, RGS20 were up-regulated in metastatic melanoma [43].  
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Coherent anti-Stokes Raman Scattering imaging revealed that free fatty acids (FFA) induced 
lipid accumulation in the cancer cells. FFA accumulation could adversely affect the cell-cell 
contact and promotes tissue invasion. FFA accumulation was positively correlated with the 
extent of metastasis [44]. The blocking of the lipogenesis either by pharmacological drugs or 
using antisense shRNA resulted in the inhibition of tumor growth and metastasis after anti-
angiogenic treatment [45, 46]. 
The higher levels of the choline related compounds were not only due to the biosynthetic 
pathways but also due to oncogene-induced activation of phosphatidyl choline and 
phosphatidyl ethanolamine-specific phospholipases resulting in the accumulation of choline 
related compounds in tumorous or actively proliferating cells [47]. Differences in the 
concentration of choline-containing compounds could be considered as an indicator for 
accessing the clinical response of cancer to chemotherapy. The outcome of the chemotherapy 
could be considered as positive if the choline-containing compounds decrease after the 
chemotherapy [48]. It was already reported that metastatic melanoma of lymph node can be 
detected using proton NMR spectroscopy with the sensitivity of 92.9% and specificity of 
90.3% [49]. Proton NMR chemical shifts of choline could alone separate the melanoma 
biopsies from non-melanoma biopsy with 69% accuracy [50].  Another study reported 
elevated levels of choline, taurine, lactate and amino acids like alanine, lysine, glutamine and 
glutamate in the biopsies could be the potential biomarkers for the identification of both 
primary and secondary melanoma cells [51]. From these studies, it was evident that proton 
NMR spectroscopy is capable enough in discriminating melanoma cells from non-melanoma 
cells. 
The biomarkers identified by the MRI coupled with 1H-MRS and proton nuclear magnetic 
resonance spectrometry (1H-NMR) could be correlated, as both these methods evolve from 
the same principle where the former was the addition of imaging to the later [52]. In a recent 
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study, Proton Nuclear Magnetic resonance spectrometry identifies a unique chemical shift 
biomarker 1.28 ppm for the identification of the neural stem and progenitor cells (NPC). This 
method was used to determine the NPC in the live mouse using the same biomarker under 
proton magnetic resonance spectroscopy (1H-MRS) [53]. From the previous studies, it is 
clear that magnetic resonance can be employed for cancer diagnosis using the lipid signals, 
but the specificity of the magnetic resonance method for detecting cancerous tissues is still 
not well established. 
  
 The objective of this study is to access the specificity of proton NMR spectrometry in 
characterizing cell lines. We hypothesize that the differences between these biologically very 
close cancer cells can be deduced by proton NMR. To test this hypothesis, we explore the 
specificity of proton NMR method by characterizing the primary and metastatic melanoma 
cells that were extracted from a single donor.  The specimens we selected for this study were 
WM 115 (Primary melanoma) and WM 266 (Metastatic melanoma) cell lines. These cells are 
closely associated to one another as they are excised from the same donor and vary only in 
the stages of cancer. We also explored the differences in these cells grown as adherent cells 
and as multi-cellular tumor spheroids using proton NMR. If our hypothesis is correct, then it 
is evident that proton NMR shows high specificity and suitable for cellular level 
characterization. 
 
2.2. Methods and materials: 
2.2.1 Cell culture: 
 WM-115 (Human primary melanoma) and WM-266 (Human metastatic melanoma) cells 
were purchased from American Type Culture Collection (ATCC), USA. These cells were 
cultured in Eagle's modified essential medium (EMEM) with 10% fetal bovine serum (FBS). 
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For the comparison of different cell lines in-vitro by nuclear magnetic resonance (NMR), it is 
necessary that the cells should have the same histologic origin and same growth medium 
[38]. All the experiments were carried out in triplicates for both the cell lines.  
 
2.2.2 Extraction of the intact cells: 
 The cells were cultured until they reached 90-95% confluence. The cells were washed twice 
with DPBS and harvested by trypsinization. The viability of the cells was checked by 
hemocytometer using bromophenol blue dye exclusion as a criterion for distinguishing live 
and dead cells.  The samples with over 95% of viable cells were assumed to be suitable for 
the NMR spectrometry.  The cells were diluted so that each sample has 1 x 107 cells.  
 
2.2.3 Formation of cellular spheroids: 
 For the spheroids formation, the cells were grown under 2D culture condition and harvested 
using trypsinization. The harvested cells were checked for viability as described above. These 
cells were diluted to 2.5 x 106 cells/mL, and each sample is an aliquot of 4 mL containing 1 x 
107 cells. The diluted cell samples were drawn into 20µL droplets on the lid of the petri dish. 
The petri dish was filled with 10mL of DPBS which forms the hydration chamber. The petri 
dish lid was gently inverted and placed in the incubator for the spheroid formation. The petri 
dish was then incubated for three days. After three days, the spheroids could be observed by 
the naked eye as white spheres. The spheroids were harvested, and 600µL of D2O was poured 




Figure 2.1: Experimental design 
2.2.4 Nuclear magnetic resonance (NMR) spectrometry: 
We performed one-dimensional 1H NMR spectroscopy (DRX500, Bruker USA) on the 
collected samples and matched controls using deuterated water (D20) as the proton NMR 
solvent. The acquired proton NMR spectral data was Fourier-transformed followed by phase 
and baseline correction using the Bruker XWinNMR software version 3.5. All the spectrums 
were aligned using the Mnova 11 software. The peak lists were extracted for the metabolite 
identification. The peak list was given as input to the MetaboAnalyst 3.0 online statistical 
software (http://www.metaboanalyst.ca, Canada) for statistical analysis [54]. 
 
2.3. Results: 
2.3.1 NMR spectrum of the melanoma cells from monolayer culture and spheroid 
culture: 
The peaks were binned together by the moving window of 0.03 ppm and a step of 0.015 ppm, 
which results in a group of 131 chemical shifts. The binned data was then normalized using 
generalized log transformation and auto scaling.  
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2.3.2 Chemical shift markers identified using Proton NMR analysis: 
 One-way ANOVA was performed for the identification of the statistically significant 
chemical shifts (p-value <0.05). We focus only on the qualitative markers as they are more 
relevant for the clinical translation of this study. In the monolayer culture, the 1H NMR 
spectrum of the primary and metastatic melanoma cells were almost similar and varied only 
in their intensity (quantitative markers) expect the chemical shift at 5.86 ppm.   
In the spheroid culture, we had observed several qualitative chemical shift markers for both 
primary and metastatic melanoma spheroids. Eight (3.58 ppm, 3.60 ppm, 3.67 ppm, 3.75 
ppm, 4.12 ppm, 4.39 ppm, 6.16 ppm, 8.07 ppm) chemical shift markers were observed in the 
primary melanoma spheroids and one marker namely 8.25 ppm for metastatic melanoma 





Figure 2.2: 1D 1H NMR spectra showing the qualitative chemical shift markers; Red font: 
Qualitative chemical shift markers between WM115 spheroids and WM266 spheroids; 
Green font: Qualitative chemical shift markers between WM115 monolayer and WM266 
monolayer; Black Font – Boxed: Qualitative chemical shift markers between monolayers 
and spheroids irrespective of the type of cell lines.   
 
Melanoma cells were observed to behave differently with different cell culture methods. In 
this analysis, we are reporting the chemical shifts that were unique to the cell line by 
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excluding the chemical shifts that were specific to the cell culture method, irrespective of the 
cell lines.  Comparison of primary melanoma cells cultured as monolayer and as spheroid 
yields 5 chemical shift markers (1.16 ppm, 2.71 ppm, 2.74 ppm, 3.04 ppm, 3.25 ppm) for 
primary melanoma cells cultured as monolayer and 10 chemical shift markers (2.19 ppm, 
2.72 ppm, 2.93 ppm, 3.58 ppm, 3.61 ppm, 4.02 ppm, 4.12 ppm, 4.39 ppm, 6.07 ppm, 6.17 





Figure 2.3: 1D 1H NMR spectra showing the qualitative chemical shift markers between 
WM115 monolayer and WM115 spheroids.  
 
 
Similarly, in the case of metastatic melanoma cells, 3 chemical shift markers (3.08 ppm, 
3.72-3.75 ppm, 3.90 ppm) were observed for metastatic melanoma cells cultured as 
monolayer and 2 (3.19 ppm and 3.48 ppm) chemical shift markers were found in metastatic 
melanoma cells cultured as spheroids (Figure 2.4, Table 2.1). 
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Figure 2.4: 1D 1H NMR spectra showing the qualitative chemical shift markers between 
WM266 monolayer and WM266 spheroids.  
 
In this study, we also intend to identify chemical shift markers with respect to the culturing 
method irrespective of the type of cell line. We were able to determine 4 chemical shift 
markers (2.85 ppm, 3.22 ppm, 3.96 ppm, 5.29 ppm) found only in the cells grown as 
monolayer and 10 chemical shift markers (2.72 ppm, 3.63 ppm, 3.66 ppm, 3.78 ppm, 4.05 
ppm, 4.21 ppm, 4.32 ppm, 7.12 ppm, 7.44 ppm, 7.83 ppm) found specific to the cells grown 
as spheroids (Table 2.1).    
 






1 2D Primary 
Melanoma 
5.86 (d) Guanosine [55] 
2 Metastatic 
Melanoma 
- - - 
3 3D Primary 
Melanoma 
3.58 (d) Threonine [56] 
[57] 
3.60 (d) Threonine [58] 
3.67 (s) Glucose [57] 
3.75 Glutamine  
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4.12 (t) Glycerophospoethanolamine [59] 
[60] 
4.39 (s) N-acetylgalactosaminitol [61] 
6.16 (d) Glucose [62] 
8.07 (s) Nh2 [63] 
4 Metastatic 
Melanoma 
8.25 (s) ATP [64] 
5 Primary 
Melanoma 
2D 1.16 (s) Lipids [65] 
2.71 (s) Dimethylamine [66] 
2.74 (s) Dimethylamine [67] 
3.04 Creatine/phosphocreatine  [59] 
[68] 
[69] 
3.25 (s) Choline head groups of 
phospholipids 
[70] 
6 3D 2.19 (s) Adipate [71] 
2.72 (t) Unassigned   
2.93 (s) Dimethylglycine [60] 
3.58 (d) Threonine [57] 
3.61 (d) Glycerol [72] 
4.02 (s) 2 hydroxyglutarate [73] 
[74] 
4.12 (t) Glycerophosphoethanolamine  [72] 
4.39 (s) N-acetylgalactosaminitol [61] 
6.07 (d) Unassigned  
6.17 (s) Unassigned  
7 Metastatic 
Melanoma 





3.90 (s) Glucose [76] 
8 3D 3.19 (s) O-acetylcarnitine [71] 
3.48 (s) Unassigned  
9 2D 2.85 (s) Asparagine [77] 
3.22 Choline [59] 
3.96 (t) β-Cyclodextrin [78] 
5.29 (s) Hc–ch (l, ch)  [75] 
10 3D 2.72 (t) Unassigned  
3.63 (s) Glycerol [72] 
3.66 Glycerol/inositol [72] 
[79] 
3.78 Phosphoinositol [79] 
4.05 (t) Ethanolamine [79] 
4.21 Phosphocholine [72] 
4.32 Glycerophosphocholine  [65] 
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7.12 (s) Ar-H [65] 
7.44 (d) Unassigned   
7.83 (s) Amide (-NH) [71] 
Table 2.1: List of qualitative chemical shift markers and its chemical shift assignment. 
 
Partial least square - discriminant analysis (PLS-DA) and clustering analysis performed 
between the primary and metastatic cells showed that culturing method had a more dominant 
influence over their 1H NMR spectrum than the cell line differences (Figure 2.5 and 2.6). 
 
Figure 2.5: Dendrogram showing distinct clusters of primary and metastatic melanoma cells 
cultured as monolayer and spheroids. This shows the impact of the cell culturing method. 
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Figure 2.6: PLS-DA plot showing the variance between the primary (PM) and metastatic 




2.4.1 Guanosine as the biomarker for primary melanoma in monolayer culture:  
This chemical shift 5.86, which was unique to the primary melanoma cells cultured as 
monolayer was assigned to guanosine, which is an integral part of the cGMP, an important 
second messenger in various intra-cellular signal transduction pathways. This observation 
suggested that in monolayer culture, primary melanoma (WM115) and metastatic melanoma 
(WM226) vary only in the guanosine related pathways. 
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2.4.2 Primary melanoma spheroids and metastatic spheroids vary in glucose 
accumulation and phospholipid composition:  
The identified chemical shift markers of primary melanoma spheroids were assigned to 
threonine (3.58 ppm, 3.60 ppm), glucose (3.67 ppm, 6.16 ppm), glycerol-
phosphoethanolamine (4.12 ppm) N-acetyl-galactosaminitol (4.39 ppm) and NH2 proton 
(8.07 ppm) (Table 2.1). The chemical shift marker of the metastatic melanoma spheroids was 
assigned to ATP (8.25 ppm). The primary melanoma spheroids suggest the presence of amino 
acid threonine which could indicate the presence of a membrane protein that was rich in 
threonine. Threonine had been reported in the literature as a biomarker for ER (Endocrine 
hormone receptor) positive breast cancer [57]. Interestingly primary melanoma spheroids had 
been found to have glucose, a key energy source that was not detected in metastatic 
melanoma spheroids. It had been shown that during the detachment of cells from the 
extracellular matrix, the cancer cells stopped the glucose consumption that resulted in 
energetic stress.  In melanoma, it was shown that the ROS levels increase dramatically during 
metastasis, which could be attributed to the cessation in the glucose uptake. When the 
glucose consumption was stopped the ATP production would cease but we observed ATP as 
the biomarker for metastatic melanoma, this is because once the ATP level starts to decline 
AMP –activated protein kinase (AMPK) will be activated and inhibits fatty acid synthesis 
and activate fatty acid oxidation pathway. This shift in the fatty acid metabolism resulted in 
the generation of NADPH and promoted the production of α-ketoglutaric acid from isocitric 
acid, which also increased the NADPH. This NADPH which is generated by the AMPK 
activation could enter into electron transport chain resulting in the synthesis of ATP [80]. N- 
acetylgalactosaminitol, observed in the primary melanoma spheroids, forms an integral part 
of cancer associated glycoproteins [84]. 
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2.4.3. Differences in the cell culturing method is primarily reflected in the phospholipid 
composition:  
The comparison of the chemical shifts of the cells cultured as monolayers and cells cultured 
as spheroids irrespective of the cell line differences we could observe chemical shift 
signatures for both monolayer cultures as well as the spheroid cultures. The chemical shift 
signatures of the monolayer cultures were assigned to Asparagine (2.85 ppm), choline 
compounds (3.22 ppm), β-Cyclodextrin (3.96 ppm), and lipids (5.29 ppm). From our data, 
the presence of lipids and choline compounds, which formed the plasma membrane were 
evident in the monolayer cultures as the more cellular surface area had been exposed 
compared to the cells in the spheroid culture. The triplet at 3.96 is assigned to β-
Cyclodextrin, but the biological origin of this compound is unclear. They have a very 
interesting property of forming inclusion complexes with various lipophilic compounds [78]. 
 
On the other hand, the chemical shift signatures of the spheroids were assigned to glycerol 
(3.63 ppm and 3.66 ppm), inositol (3.66 ppm), phosphoinositol (3.78 ppm), ethanolamine 
(4.05 ppm), phosphocholine (4.21 ppm), glycerophosphocholine (4.32 ppm) and amide group 
(-NH) (7.83 ppm). The presence of glycerol, inositol, ethanolamine, phosphocholine and 
glycerophosphocholine shows the existence of the glycerophospholipids, the key component 
of cell membrane suggests that the multicellular spheroids closely resembles the cells in-vivo.  
 
2.4.4: Differences in the culturing method is reflected in the phospholipid of primary 
melanoma cells: 
Primary melanoma cells showed differences in their behavior with respect to the culturing 
method. The markers of primary melanoma cultured as monolayer were assigned to lipids 
(1.16 ppm, 5.29 ppm), dimethylamine (2.71 ppm, 2.74 ppm), phosphocreatine (3.04 ppm) 
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and choline head groups of phospholipids (3.25 ppm). Thus primary melanoma cells in 
monolayer produce certain standard cell membrane components like choline and lipids. They 
also contain phosphocreatine a key reserve for the high energy phosphates, which could be 
utilized for the formation of ATP. Dimethylamine could be the result of L-citrulline 
formation from asymmetric dimethylarginine (ADMA) [82].   
 
On the other hand, when these same primary melanoma cells were cultured as spheroids they 
produce some unique chemical shift signatures that could be assigned to adipate (2.19 ppm), 
dimethylglycine (2.93 ppm), threonine (3.58 ppm), glycerol (3.61 ppm), 2-hydroxy glutarate 
(4.02 ppm), glycerophosphoethanolamine (4.12 ppm), N-acetylgalactosaminitol (4.39 ppm). 
Adipate is an acidity regulator, which plays a vital role in maintaining the acidity balance in 
the cellular microenvironment. This acidity regulation is necessary as the cells would produce 
lactate as a result of their metabolic activity. Glycerol and glycerophosphoethanolamine were 
the integral components of the phospholipids in the cell membrane. These observations 
suggested that the 3D architecture of the multicellular spheroids of the metastatic melanoma 
cells vary from their monolayer counterpart primarily in the plasma membrane composition. 
2-hydroxy glutarate (2-HG) is a well known as oncometabolite which will usually 
accumulate in malignant cells due to the gain of function mutation of the isocitric 
dehydrogenases (IDH). Accumulation of the 2-HG inhibited the 2- oxoglutarate-dependent 
oxygenases which in turn inhibits histone lysine demethylases thus impairing the epigenetic 
modifications of histones [83,84]. These findings proved the closeness of the 3D spheroids 
with the in-vivo tissues. Previous studies on the rectal adenocarcinoma had shown that N-
acetylgalactosaminitol forms an integral part in all the four oligosaccharides isolated from the 
mucin-like glycoprotein of rectal adenocarcinoma. Apparently, N-acetylgalactosaminitol 
involves the formation of cancer associated glycoproteins [81]. 
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2.4.5: Glucose accumulation and O-acetyl carnitine mark the differences between the 
metastatic melanoma cells cultured as monolayer and as spheroids: 
The chemicals shifts of the monolayer cultured cells suggested the presence of Methyl-lysine 
(3.08 ppm), glucose (3.90 ppm), and whereas the chemical shifts of metastatic melanoma 
spheroids revealed the presence of O-acetyl carnitine (3.19 ppm).  This data showed that 
methyl-lysine and glucose resonating at 3.08ppm and 3.90 ppm were the qualitative markers 
for the metastatic melanoma cells cultured as monolayer but the same cell line when cultured 
as spheroids they do not produce chemical shift peaks at 3.08 ppm and 3.90 ppm instead they 
produce a chemical shift at 3.19 which is assigned to O-acetyl carnitine. It is also previously 
reported that 3.08 ppm chemical shift manifested the presence ofthe SH2 group in taurine 
[85, 86]. In these studies, the 3.08 ppm chemical shift has appeared as a triplet, but in our 
data, the 3.08 ppm shift appeared as a singlet. In a previous report, where the chromatin core 
particles where analyzed using proton nuclear magnetic resonance spectrometry encountered 
the 3.08 ppm chemical shift as a singlet, and it was assigned to the CH2 group proton of the 
methyl lysine [75]. Hence, chemical shift at 3.08 ppm is attributed to proton from the CH2 
group of the methyl lysine. Methylated amino acids especially methyl-lysine and methyl-
arginine in the chromatin plays a vital role in recruiting proteins that induce structural 
changes in chromatin thus influencing gene expression and repression [87].  
 
2.4.6. Clinical projections of this study: 
In this study, we used the 3D spheroids, to minimize the limitations in its clinical translation. 
Flat monolayer cultures were the simple cancer models, having a physiologically uniform 
environment and lacked cell to cell attachment, which is not the case in the actual tumor 
environment. In in vivo tumors, there exists cell to cell attachment, oxygen gradient, nutrition 
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gradient and waste gradient. This in vivo tumor environment could be reproduced in the 3D 
spheroids with ease. This behavior can be reproduced by culturing cells as 3D spheroids [88]. 
2D flat monolayer cultured cells showed apical-basal polarity and lacks in the histological 
differentiation of the in vivo tumors whereas one could obtain the histological morphology 
similar to that of the in vivo tumor in 3D spheroids [89, 90]. The cells in-vivo tumor exhibits 
phenotypic heterogeneity in the cell proliferation rate, gene expression, and differentiation 
which led to the heterogeneity in the function and morphology and 3D spheroids could 
capture all this phenotypic heterogeneity [91]. Few cells exhibited the stem cell-like 
characteristics such as self-renewal and undifferentiated multipotent phenotype called cancer 
stem cells (CSCs) [92]. These CSCs were observed in both in vitro  3D tumor spheroids and 
in vivo tumors [93] and these stem-ness related genes were found to be upregulated in 3D 
spheroids compared to the 2D monolayers [94]. All the above studies showed the cells grown 
as 3D spheroids resemble closely to the cells in the in vivo tumors. Thus, we expect there will 
not be any potential limitations in the clinical translation of the results of this study and of 
course an actual clinical translational study is necessary to corroborate this statement. 
2.5. Conclusion: 
 In this study, we showed that the two closely associated cell lines, which were obtained from 
the same donor and differed only in the stages of melanoma could be identified as different 
cell lines by employing 1D 1H NMR spectrometry. Our study suggests that the glucose 
accumulation and phospholipid composition vary significantly between the primary and 
metastatic cells lines that were obtained from single donor and also with the cell culturing 
methods. These results encourage further researches on understanding the effects of 
phospholipid and glucose accumulation in cancer development, progression, and invasion. 
This study also showed that the method of cell culture would drastically affect the 
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phospholipid composition of the cells and also depicts that the cells in spheroid culture 
closely resembled the cells in-vivo. 
 
2.6. Summary: 
Primary melanoma cells (WM 115) and metastatic melanoma cells (WM 266) extracted from 
single donor were cultured in 2D as well as 3D cultures. These cells were characterized using 
proton NMR spectrometry and the qualitative chemical shifts markers were identified and 
discussed. In monolayer culture (2D), one qualitative chemical shift marker for primary 
melanoma cells is observed. In spheroid cultures (3D), nine significant chemical shifts, of 
which eight markers were specific for primary melanoma spheroids, whereas one marker was 
specific to metastatic melanoma spheroids were observed. This study suggests that the 
glucose accumulation and phospholipid composition vary significantly between the primary 
and metastatic cells lines that are obtained from single donor and also with the cell culturing 
methods. 14 qualitative chemical shift markers were obtained in the comparison between 
monolayer culture and spheroids cultures irrespective of the differences in the cell lines. 
Among which four were unique to monolayer cultures whereas ten chemical shifts were 
specific to the spheroid cultures. This study also shows that the method of cell culture would 
drastically affect the phospholipid composition of the cells and also depicts that the cells in 
spheroid culture closely resembles the cells in-vivo. This study shows the high specificity of 
proton NMR spectrometry in characterizing cancer cell lines and also lists the variations in 
the glucose accumulation and phospholipid composition between the primary and metastatic 
melanoma cell lines from the same donor. Differences in the cell culture method play a 






Identification of Gastric Cancer Biomarkers Using 1H Nuclear 
Magnetic Resonance Spectrometry. 
 
3.1. Background: 
 According to World Health Organization, gastric cancer (0.72 million deaths) ranks third in 
causing cancer death worldwide in 2012, with the highest incidence in the Asia-Pacific 
region especially in Japan, gastric cancer is much more prevalent than other countries. The 
prognosis of gastric cancer is destitute especially for the one that occurs in the cardiac region. 
Given the high global incidence rate, early detection of gastric cancer appears to improve 
survival rates. Mass screening of gastric cancer in Japan has considerably decreased the 
mortality rate. Usually, the gastric cancer is often diagnosed at the metastatic stage which is 
tough to treat [95,96]. The gastric cancer incidence is higher in developed countries whereas 
the mortality is high in developing countries, which is attributed to the lack of early detection, 
environmental changes, and lifestyle changes. Hence, the economic burden regarding 
morbidity and mortality cost will be higher in the developing countries [97]. The gold 
standard for the diagnosis of gastric cancer is esophagogastroduodenoscopy (EGD) and 
biopsy. When a doctor identifies an abnormal tissue area through EGD, a biopsy will be 
performed followed by the routine procedure for the confirmation. Even though this method 
has high specificity and sensitivity, there are several disadvantages in using endoscopy as the 
first screening tool; to mention a few, it is an invasive procedure with potential complications 
such as perforation and aspiration and is not a cost-effective screening tool for most of the 
countries. Hence, this test is out of reach for most of the people in Asia, Africa, and South 
America. This method is invasive and creates significant discomfort for the patients 
especially children and elderly. 
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One promising non-invasive way of detecting and locating cancer is by employing nuclear 
magnetic resonance as this method safe as it is non-ionizing. Cancer cells contain higher 
levels of phospholipids than normal cells, which plays a significant role in membrane 
formation to cope up enhanced cell proliferation and signal transduction. The alteration of 
phospholipid composition also plays a pivotal role in cancer invasion, metastasis, and 
expression of growth factor receptors [36, 37]. Various prior studies concluded that 1H MRS 
could be used to diagnose cancer and also to monitor responses to the cancer treatment [38-
41]. Magnetic resonance imaging and magnetic resonance spectrometry in combination can 
diagnose of prostate cancer. Prior studies have suggested that combined MRI and MRS could 
serve as a useful test for the low-risk patients. Martin et al. also recommend larger studies for 
the confirmation of this statement [98]. The lipid composition was significantly altered in the 
extracts of benign (chronic cholecystitis), intermediate (xanthogranulomatous cholecystitis) 
and malignant gallbladder tissue. This study provided proof that the lipid composition of 
cancer tissues and normal tissues vary significantly and which can be detected using 
magnetic resonance [99]. Mobile lipid resonances profiled using 1H MRS can be used to 
distinguish cervical cancer tissues, low-grade intraepithelial neoplasia, and non-cancerous 
tissues [100]. This study serves as the proof for the diagnosis of cancer using lipid signals 
from 1H magnetic resonance. These studies provide an insight that there is a possibility for 
the presence of a particular mechanism in the cancer cells that alter the phospholipids 
composition. 
In-vivo 1H magnetic resonance spectrometry can be used to quantify choline compounds in 
the breast; it is observed that the choline-containing compounds were significantly higher in 
malignancies than benign abnormalities and normal breast tissue. Sensitivity, positive 
predictive value, and accuracy of the cancer diagnosis can be enhanced when 1H MRS and 
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biopsy are employed together.  This study also proves that 1H MRS has better sensitivity, 
positive predictive value, and accuracy that biopsy [101]. 1H MRS is a potential procedure 
for detecting cancerous breast lesions that are 15mm or larger in diameter without the need of 
invasive endoscopy procedure [102].   
Magnetic resonance method identifies not only lipid biomarkers but also metabolic 
biomarkers. In human prostate tissues, 1H MRS signals of citrate, creatine, and choline 
compounds were observed. The citrate to choline ratio can be used for the cancer diagnosis. 
This ratio is lower for the cancerous tissues in comparison with the noncancerous normal 
tissues. 1H MRS is a promising method for the detection and treatment follow-up for prostate 
cancer [103]. Few studies reported that the in vitro 1H magnetic resonance spectrometry 
(MRS) of the perchloric acid extracts of the breast tissue showed resonance at 3.2 ppm, 
which was significantly high for the breast carcinoma when compared to the normal and 
benign breast tissue.  
The higher levels of the choline related compounds may be primarily attributed to the 
oncogene-induced activation of phosphatidyl choline and phosphatidyl ethanolamine-specific 
phospholipases. This phenomenon resulted in the accumulation of choline related compounds 
in tumorous or actively proliferating cells [104]. Differences in the concentration of choline-
containing compounds can be considered as an indicator for accessing the clinical response of 
cancer to chemotherapy. The outcome of the chemotherapy can be regarded as positive if the 
choline-containing compounds decrease after the chemotherapy [48]. 
 
 The biomarkers identified by the 1H-MRS and Nuclear magnetic resonance spectrometry 
(NMR) could be the same as both these methods employ the same principle. Nuclear 
magnetic resonance spectrometry identifies a unique chemical shift biomarker 1.28 ppm for 
the identification of the neural stem and progenitor cells (NPC). They could even identify the 
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NPC in the live mouse using this biomarker under proton magnetic resonance spectroscopy 
(1H-MRS) in xenografted mice [105]. This observation is possible as each cell type has 
unique cell surface receptor proteins and phospholipid composition. From the previous 
studies, it is clear that magnetic resonance can be employed for cancer diagnosis using the 
lipid signals. 
             
We hypothesize that one dimensional H1 Nuclear Magnetic Resonance (NMR) can 
distinguish between the in-vitro 3D models of the normal gastric cells and gastric cancer cells 
with reliable NMR chemical shift markers. In this study, we are using the in-vitro 3D models 
(spheroids) of the normal gastric cell line and gastric cancer cell lines to decipher the 
magnetic resonance based gastric cancer markers. The rationale for using spheroids is that it 
shows similar characteristics of the in-vivo tissues. In-vivo cells are interconnected to each 
other as well as to the extracellular matrix (ECM). Further in-vivo cells show many inherent 
properties like polarization, intercellular communication, developing the extracellular matrix 
and so on. All these unique features can be replicated in in-vitro spheroids, and these are not 
possible in 2D culture [106,107]. 
 
3.2. Methods and Materials: 
3.2.1. Cell culture 
For this study, a set of twelve gastric cancer cell lines namely SNU484, MKN28, MKN7, 
SCH, AGS, IST1, KATO3, YCC10, YCC11, N87, NUGC3 and NUGC4 and a normal gastric 
cancer cell line HS738. The Gastric cancer cells were cultured in RPMI medium with 10% 
fetal bovine serum (FBS), and the normal gastric cell line was cultured in Dulbecco's 
modified essential medium (DMEM) with 10% fetal bovine serum (FBS). All the 
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experiments were carried out in triplicates for all the cell lines along with the spent medium, 
which serves as background control. 
 
3.2.2. Formation of cellular spheroids: 
For the spheroids formation, the cells were grown under 2D culture condition and harvested 
using trypsinization. The harvested cells were checked for the viability using bromophenol 
blue dye. The samples with required viability (95%) were diluted into 2.5x106 cells/mL, and 
each sample will contain 1X107 cells i.e. 4 mL of the diluted cell suspension. The diluted cell 
samples were drawn into drops of 20µL on the lid of the sterile petri dish. The petri dish was 
filled with 10mL of DPBS for hydrating the drops. The petri dish lid was gently inverted and 
placed in the petri dish and placed in the incubator for the spheroid formation [53]. The petri 
dish was then incubated for three days. After three days, the spheroids could be observed by 
the naked eye as white spheres. The spheroids were harvested, washed twice with DPBS and 
gently suspended in 600µL of D2O. As a final step, the suspended spheroids were then 
carefully poured into the NMR tubes.       
 
3.2.3. Nuclear magnetic resonance (NMR) spectrometry 
We performed one-dimensional 1H NMR spectroscopy (DRX500, Bruker USA) on the 
collected samples and matched controls using deuterated water (D20) we used as the solvent 
(Figure 3.1). The acquired NMR spectral data was Fourier-transformed followed by phase 
and baseline correction using the Bruker XWinNMR software version 3.5. The peak lists 
were extracted for the metabolite identification. The peak list was given as input to the 
MetaboAnalyst 3.0 online statistical software (www.Metaboanalyst.ca/, Canada) for 
statistical analysis [54]. 
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3.3.1. Spheroid formation: 
Among the 12 gastric cancer cell lines, only 4 of them can form the spheroids using the 
hanging drop procedure mentioned above. The gastric cancer cell lines that can form 
spheroids were SNU484, NUGC 3, MKN28 and IST1. Among them, the spheroids formed by 
the SNU484 and MKN 28 were more compact compared to the spheroids formed by IST1 
and NUGC 3 cell lines. It is already well documented that only a limited number of cell lines 
could form spontaneous spheroids whereas, many cell lines could form only the loose 
aggregates. In a previous study, it is reported that by the addition of reconstituted basement 
membrane (rBM, Matrigel™), these loose aggregates can be transformed into spheroids 
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[108]. Another study shows that egg white can be used as the substitute for the standard 
reconstituted basement membrane-like collagen and Matrigel™, whereby in this study they 
able to establish an angiogenesis assay using egg white whose characteristics were similar to 
the results obtained using collagen and Matrigel™ [109].  These studies motivated us to try 
forming the spheroids of YCC 11 cell lines, which could not undergo spontaneous spheroid 
formation using nutrient medium supplemented with different concentration of egg white 
(ranges from 2% to 50%). Unfortunately, we were unable to generate spheroid using egg 
white (Figure 3.2). In fact, the addition of egg white decreases the aggregation of the cells 
with the increase in the concentration of egg white. 
 
Figure 3.2. Stereo microscopic images of YCC 11 cell lines fed with RPMI + 10% FBS 
supplemented with various concentrations of egg white. 
 
3.3.2. NMR spectrum of gastric cancer and normal gastric spheroids: 
The peak lists of all NMR spectrums were obtained. The peaks were grouped together by the 
moving window of 0.03 ppm and a step of 0.015 ppm, which results in a group of 117 peaks. 
The pooled data was normalized using generalized log transformation and auto scaling. 
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3.3.3. Statistical analysis of the NMR spectrums of gastric cancer and normal gastric 
spheroids: 
The statistical analysis the normalized peak lists shows 21 chemical shift peaks (Table 3.1) 
were significantly vary between the gastric cancer cell lines (SNU484, MKN28, IST1, and 
NUGC3) and normal gastric cell line (HS738). Among these 21 chemical shift peaks eight 
were present in higher intensity in the gastric cancer spheroids when compared to the normal 
gastric spheroids.  These eight peaks could be the potential magnetic resonance based gastric 
cancer markers. The rest 13 were observed to be in higher intensity in the normal gastric 
spheroids compared to the gastric cancer spheroids. The NMR markers for the gastric cancer 
spheroids ranges from 1 ppm to 4 ppm (Figure 3.3) whereas, NMR markers for the normal 




Figure 3.3: 1H NMR spectrum showing NMR markers of gastric cancer spheroids. 
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S. No Chemical shifts 
(ppm) 
FC log2(FC)* p.value 
1 3.21 332.77 8.3784 0.00021027 
2 4.02 53.079 5.7301 0.00044346 
3 4.23 44.809 5.4857 0.00096607 
4 1.13 34.183 5.0952 0.00092528 
5 2.59 16.297 4.0265 0.0067511 
6 3.01 15.039 3.9107 0.0085235 
7 2.44 7.5685 2.92 0.0012475 
8 2.47 4.7224 2.2395 0.0011457 
9 4.40 0.17478 -2.5164 0.0002721 
10 7.94 0.12923 -2.952 0.00010053 
11 3.08 0.12643 -2.9836 0.0088915 
12 4.27 0.12609 -2.9874 0.0050839 
13 5.29 0.11044 -3.1787 0.00038551 
14 5.47 0.10526 -3.248 0.0046374 
15 5.98 0.098221 -3.3478 5.67E-06 
16 6.05 0.076551 -3.7074 0.00034459 
17 4.35 0.05315 -4.2338 0.00074306 
18 4.31 0.047047 -4.4098 0.00010888 
19 5.58 0.045401 -4.4611 1.30E-11 
20 4.72 0.042526 -4.5555 1.48E-16 
21 8.02 0.02419 -5.3694 7.49E-12 
 
Table 3.1: List of NMR chemical shift markers for the gastric cancer spheroids.  *positive 
values represent the chemical shifts exhibit higher intensity in gastric cancer spheroids, and negative values 
represents the chemical shifts show high intensity in normal gastric spheroids.  
 
Furthermore, principal component analysis (PCA) and clustering analysis performed between 
gastric cancer and normal gastric spheroids depict the gastric cancer spheroids and normal 
gastric spheroids into different groups, indicating the significant variance between these cell 
lines (Figure 3.5). Heat map analysis manifests the top 25 significant (p-value <0.05) 
chemical shift markers with its relative intensities (Figure 3.6). 
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3.4.1. Formation of gastric spheroids: 
In this study, we have observed that spontaneous spheroid formation is not typical for all the 
cell lines only a few cell lines like IST 1, NUGC 3, MKN 28, SNU 484 and HS 738 can form 
spontaneous spheroids. This discrepancy is because cells interact with each other in a very 
complex and diverse manner which dictates the formation of the spontaneous spheroids in-
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vitro. In a previous study which involves eight breast cancer cell lines show that the E- 
Cadherin plays a pivotal role in the formation of spontaneous spheroids in some cell lines 
whereas the interaction between the collagen I/integrin β1 drives the cells to form 
spontaneous spheroids. Interestingly some cell lines were able to form spheroids with the 
shared responsibility of both homophilic E-cadherin and integrin β1/collagen I [110].  
3.4.2. Phospholipid metabolism is the major contributor of NMR markers for Gastric 
cancer:  
We could observe a total of eight NMR markers that are overexpressed in gastric cancer 
spheroids than normal gastric spheroids. 3.2 ppm represents the choline and choline related 
compounds [111]. Choline has been identified as the tumor marker in breast cancer and lung 
cancer [101, 112]. Choline and its derivatives have been already reported as the markers of 
cell proliferation as they play a vital role in phospholipid metabolism that forms the cell 
membrane [69]. The chemical shift 1.13 ppm has been already identified as the marker for 
cervical cancer. The serum obtained from the cervical cancer patients shows 1.13 ppm shift 
as the marker for the diagnosis of cervical cancer [113]. 
Our study identifies chemical shift at 3.01 ppm as a marker for gastric cancer. This chemical 
shift represents creatine [114,115]. Creatine was reported to the biomarker for cervical 
cancer. Ex-vivo HR-MRS analysis of the cervical tumor tissue and healthy cervical tissue 
shows a significant (p=0.004) difference in creatine [116]. Creatine is named as a potential 
biomarker for lung cancer in a study which involves analyzing the methanol-chloroform - 
water extract of non-small cell lung cancer tissues from 21 lung cancer patients [112]. These 
studies support our data which shows creatine, represented by the chemical shift at 3.01 ppm 
as the marker for gastric cancer. Another important gastric cancer biomarker that we have 
discovered is the chemical shift at 4.02 ppm, which represents 2-hydroxyglutarate. World 
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Health Organization reported that two hydroxyglutarate is the key biomarker for the 
identification of IDH (Isocitrate dehydrogenase) mutated glioma as the mutation in these 
genes could result in the accumulation of the 2-hydroxyglutarate [117]. In our knowledge, we 
are the first to report 4.02 ppm as the biomarker for gastric cancer. 
Another interesting chemical shift marker for gastric cancer is the chemical shift at 2.47 ppm. 
This marker indicates glutamine, a common amino acid.  Previous studies have reported 
glutamine as the marker for the slightly malignant prostate cancer [118]. Our study depicts 
glutamine as the common NMR marker for gastric cancer as well as prostate cancer. The 
chemical shift marker 2.59 ppm is assigned to methylamine. Methylamine has been reported, 
as the key biomarker is cancers of the alimentary canal. Methylamine, as represented as the 
chemical shift 2.59 ppm, has been reported as the rectal cancer marker. Methylamine 
involves in the metabolism of another important cancer biomarker namely choline [69]. It is 
reported that methylamines can cause hepatocarcinogenesis in rats [119]. It is also reported 
that higher levels of methylamine could induce gastric cancer [120]. 2- oxoglutarate plays a 
pivotal role in the activity of the 2- oxoglutarate-dependent dioxygenases. Increase in the 
cellular level of 2- oxoglutarate elevates the activity of the 2- oxoglutarate-dependent 
dioxygenases, which will result in many crucial events like activation of hypoxia inducible 
factors (HIF 1), disturbances in the epigenetic regulation and reduction of the carnitine 
synthesis. These events eventually lead to tumor viability and metastasis [121]. Our study 
depicts the presence chemical shift marker for gastric cancer at 2.44 ppm which is assigned to 
2 – oxoglutarate [122]. 
3.4.3. Glycosylated derivatives are the key NMR markers unique to the normal gastric 
spheroids: 
We observed 13 NMR chemical shift markers that are unique to the normal gastric spheroid 
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that is not found or varies significantly (p<0.05) from the gastric cancer spheroids. The 
assignment of these markers and their role were as follows: The chemical shifts at 4.40 ppm 
and 4.27 ppm indicate the oligosaccharide alditols, these compounds consist of the Galβ1-
3(GlcNAcβ1-6)- GalNAc-ol core. This core contains the O-glycosidic structures. These 
structures are represented by the chemical shifts of 4.40 ppm and 4.27 ppm [123,124]. 
 Our data depicts the strong evidence for the presence of UDP-glucose. Chemical shift 
resonance at 8.02 ppm represents the proton in the NH group of the uracil ring [125,126], 
whereas the NMR resonances at 7.94 ppm and 5.98 ppm mark the presence of the protons 
linked to the C6 and C5 of the uracil ring [127]. The presence of the phosphate group is 
indicated by the chemical shift resonance at 4.35 ppm [128]. This evidence proves the 
existence of the uridine diphosphate in the normal gastric spheroids. There must be a glucose 
molecule which is hinted by the chemical shift resonance at 4.27 ppm, and that is linked with 
the UDP via anomeric carbon as we also observed a chemical shift resonance at 5.58 ppm 
which manifests the occupancy of the proton-linked with the anomeric carbon of glucose 
[129].   
It is reported that increase in the synthesis of glycogen from glucose results in the decrease in 
the cellular concentration of the UDP-glucose [130]. On the other hand, the increased 
glycogen synthesis has been demonstrated in many types of cancer [131]. These studies 
support our data, which shows a significant increase in the UDP-glucose in the normal gastric 
spheroids compared to the gastric cancer spheroids. The chemical shift at 4.72 ppm and 4.31 
ppm implies β (1-4) N-acetyl galactosamine, whereas the 4.72 ppm and 4.31 ppm denotes H-
1β [132] and β(1-4) GalNAc respectively [133,134]. 4.31 ppm precisely indicates 
galactosamine as well as the acetylation of galactosamine in N-acetyl galactosamine 
[133,135]. Both 4.72 ppm, as well as the 4.31ppm, reveals the presence of β (1-4) 
	 60	
configuration [132,134]. 
Chemical shift at 5.47 points out the H linked to the C1 of the N-acetyl galactosamine of 
UDP-GalNAc [136]. In another study, it also denotes the existence of a-D-GlcpNAc [137]. 
Another study describes this chemical shift for H-1 of α-Gal-1-P [138]. These observations 
strongly suggest the presence of UDP-GalNAc as we already have evidence for the presence 
of UDP. The chemical shift at 5.29 ppm manifests the proton from anomeric carbon [139] 
and specifically at β anomeric configuration [140]. Prior study has reported that this chemical 
shift indicates the galactopyranose residue at the reducing end of glycolipids [139]. Another 
report which characterizes the liver fats shows that 5.29 ppm belongs to the olefinic group in 
the triglycerides [141]. All this data suggests that the gastric cancer spheroids and normal 
gastric spheroids vary significantly in the composition of lipid and lipid derivatives. Another 
chemical shift marker which is considerably higher in normal gastric spheroids, 6.05 ppm is 
assigned to NH2 group in a prior study [142,143]. Interestingly another report had assigned 
this chemical shift to the protons from the olefinic group [144,145]. 
 
Finally, the chemical shift at 3.08 is attributed to proton from the CH2 group of the methyl 
lysine. 3.08 ppm was previously reported that this chemical shift manifests the presence of 
the SH2 group in taurine [85]. Another study where proton nuclear magnetic resonance 
spectrometry is utilized for the identification of the neural cell types supports the assignment 
of 3.08 ppm to the SH2 of taurine [86]. In these studies, the 3.08 ppm chemical shift has 
appeared as a triplet, but in our data, the 3.08 ppm shift appeared as a singlet. In a previous 
report, where the chromatin core particles were analyzed using proton nuclear magnetic 
resonance spectrometry encountered the 3.08 ppm chemical shift as a singlet, and it was 
assigned to the CH2 group proton of the methyl lysine [75]. Methylated amino acids 
especially methyl-lysine and methylarginine in the chromatin plays a vital role in recruiting 
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proteins that induce structural changes in chromatin thus influencing gene expression and 
repression [87]. Our data suggests that the gastric cancer spheroids have significantly lesser 
methylated amino acids thus impairing its epigenetic control over gene expression.   
 
3.4.4. Feasibility of clinical translation of this study: 
In this study, we used the 3D spheroids, to minimize the limitations in its clinical translation. 
Flat monolayer cultures are the simple cancer models, where the cells adhere to the poly-D- 
Lysine treated plastic surfaces or glass surfaces. These cancer models have a physiologically 
stable environment and lack cell to cell attachment, which contradicts the actual tumor 
environment. In in vivo tumors, there exists cell to cell attachment, oxygen gradient, nutrition 
gradient and waste gradient. These features of in vivo tumor environment could be 
reproduced in the 3D spheroids with ease. Solid tumors proliferate in a differential manner 
whereas the proliferation is higher at the periphery than the core region which is attributed to 
the oxygen and nutrient gradient. This behavior could accurately be depicted by the 3D 
spheroids whereas, cells grown in 2D flat monolayer depicts uniform proliferation [88].  2D 
flat monolayer cultured cells shows apical-basal polarity as only one side of the cell adheres 
to the surface, and that has a huge impact on the cellular function. As these 2D cultured cells 
always depict simple geometry, they do not show histological differentiation of the in vivo 
tumors, but by just growing cells as 3D spheroids one could obtain the histological 
morphology similar to that of the in vivo tumor type from which the cell lines were derived 
[89, 90]. The cells in a tumor exhibit phenotypic heterogeneity in the cell proliferation rate, 
gene expression and differentiation which leads to the heterogeneity in the function and 
morphology [91].  Tumor spheroids could capture this phenotypic heterogeneity as they have 
oxygen and nutrient gradients.  Few cells exhibit the stem cell-like characteristics such as 
self-renewal and undifferentiated multipotent phenotype called cancer stem cells (CSCs) 
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[92]. These CSCs are observed in both in vitro 3D tumor spheroids and in vivo tumors [93] 
and these stemness-related genes are found to be upregulated in 3D spheroids compared to 
the 2D monolayers [94]. The gene expressions profiles including the expression of 
transcription factors of a cell line grown as 3D spheroids were divergent compared to the 
same cell line cultured 2D monolayers [90, 146, 147]. All the above studies show the cells 
grown as 3D spheroids resemble closely to the cells in the in vivo tumors. Thus, we expect 
there will not be any potential limitations in the clinical translation of the results of this study 




In this study, we decipher the NMR markers for differentiating gastric cancer spheroids and 
normal gastric spheroids. We can identify eight markers that are unique to the gastric cancer 
spheroids that are analyzed in this study. We also demonstrated that 13 markers are 
significantly lesser in the gastric cancer spheroids compared to their normal counterpart. 
These markers indicate that the cancerous and non-cancerous spheroids differ majorly in the 
energy metabolism, composition of lipid and lipid derivatives. These results open up avenues 
for the researches focusing on identifying novel lipid targets in gastric cancer. This study also 
depicts that the formation of spontaneous spheroids is not a common trait for all the cell lines. 
 
3.6. Summary: 
Existing gastric cancer diagnosing methods were invasive; hence, a reliable non-invasive 
gastric cancer diagnosing method is needed. As a starting point, we used 1H NMR for 
identifying gastric cancer biomarkers using a panel of gastric cancer spheroids and normal 
gastric spheroids. We were able to determine eight chemical shift biomarkers for gastric 
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cancer spheroids. Our data suggests that the cancerous and non-cancerous spheroids 
significantly differ in the lipid composition and energy metabolism. These results encourage 
the translation of these biomarkers into in-vivo gastric cancer detection methodology using 
MRI-MS. Although proton NMR-based cancer detection is promising, the cost of MRI-MS 
and the need for the experienced operator suggest that this method is not suitable for 
developing and under developed nations. So, the decision to look for other alternative ways 
of cancer biomarker identification was taken and found prior studies where Volatile organic 
compounds (VOCs) were used as cancer biomarkers. But we discovered that all the existing 
literature on VOC based disease detection were based on the 2D monolayer cultures. Hence, 
the decision to develop and standardize a method for VOCs based characterization of in vitro 






























Comparison of the volatile organic compound signatures of 




The volatile organic compound (VOCs) signature of the cancer cells forms the basis of 
volatile-based cancer detection. There are several prior studies, demonstrating the unique 
VOC signatures of various cancer cells in vitro. Zimmerman et al. observed the qualitative 
differences in the VOC metabolites, methyl dodecane, undecan-2-ol, pentadecane-1-one, 
decane-1-ol, heptane-1-ol, and nonane-2-one. Between the colon cancer cell lines and the 
normal colon cell lines [148]. They concluded that the cancer cells and healthy cells differed 
mostly in the ketones and alcohols. Spring et al. observed the increased production of 2 ethyl-
1-hexanol and 2-methyl pentane in the lung cancer cell lines when compared to the controls. 
They also validated that 2-methyl pentane was present in the breath of the lung cancer 
patients. They also observed the differential consumption of the headspace VOCs between 
the lung cancer cell lines and the controls [149]. Abaffy et al. found 3 VOCs that were 
differentially expressed in the melanoma cell lines and the normal skin cell lines. These 
VOCs were long chain alkanes, namely 4-methyl decane, dodecane and undecane [150]. 
Hanai et al. observed the differential expression of seven VOCs mostly ketones between the 
lung cancer cells and the healthy lung cells [151]. These seven compounds were dimethyl 
succinate, 2-pentanone, phenol,2-methyl pyrazine,2-hexanone, 2-butanone, and 
acetophenone. They validated the in-vitro experimental results with the in-vivo xenografted 
mice model. The VOCs observed in the xenografted mice urine, and the in-vitro cells were 
demonstrated to be statistically similar.  
Troppmair et al. found that 2,3,3-trimethylpentane, 2,3,5-trimethylhexane, 2,4-
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dimethylheptane, and 4-methyloctane were released by the lung cancer cell line CALU-1 and 
this cell line also consume acetaldehyde, 3-methylbutanal, butyl acetate, acetonitrile, 
acrolein, methacrolein, 2-methylpropanal, 2-butanone, 2-methoxy-2-methylpropane, 2-
ethoxy-2- methylpropane, and hexanal. They also observed that there exists a difference in 
the consumption of the VOCs between different cell lines [149].  Pawel et al. found the 
hepatocellular carcinoma cells consumes nine and release twelve VOCs. The consumed 
VOCs include 2-methyl 2-propenal, 2-methyl propanal, 2-ethylacrolein, 3-methyl butanal, n-
hexanal, benzaldehyde, n-propyl propionate, n-butyl acetate, and isoprene whereas the 
released VOCs were 2-pentanone, 3-heptanone, 2-heptanone, 3-octanone, 2-nonanone 
(dimethyl sulfide, ethyl methyl sulfide, 3-methyl thiophene, 2-methyl-1-(methylthio)- 
propane and 2-methyl-5-(methylthio) furan), n-propyl acetate, and 2-heptene [152].  
Luca et al. found that the VOC signatures are capable of discriminating breast cancer cells for 
various characteristics, which include transformed condition, cell doubling time (CDT), 
Estrogen and Progesterone Receptors (ER, PgR) expression and HER2 overexpression [153]. 
Kristin et al. studied all the possible ways of VOC analysis such as in situ, gas subsampling 
and nutrient solution subsampling. They conclude that two-dimensional monolayer cell 
culture method which was currently employed is inappropriate for VOC analysis. Reena et al. 
studied the VOC signatures of the two lung cancer cell lines A549 and W138VA13. They 
observed decane and heneicosane in the A549 cell line and 1-heptanol and heptadecane in 
W138VA13 cell line [154].  
All the prior studies in this research area were conducted using two-dimensional culture 
method, which is not directly representative of the in vivo condition. Thus, the results would 
not be comparable with the cells in vivo. Two-dimensional models have physiologically 
uniform cellular micro-environment and lack cell-to-cell attachment, but in vivo, there exists 
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cell to cell attachment, oxygen gradient, nutrition gradient and waste gradient. Solid tumors 
exhibit differential proliferation, i.e.; proliferation is higher at the periphery than the core 
region due to the gradients cells in 2D models depicts uniform proliferation [88].  Cells in 
two-dimensional models show apical-basal polarity due to their surface attachment, and that 
has a huge impact on the gene expression and cellular function. Further, these 2D cultured 
cells do not show histological differentiation of the in vivo tumor [89, 90]. The cells in a 
tumor exhibit phenotypic heterogeneity, which results in the heterogeneity in both function 
and morphology [91]. The gene expression profiles including the expression of transcription 
factors of a cell line grown in 3D are divergent compared to the same cell line cultured 2D 
[90, 146, 147]. It is possible to replicate all the features of the in vivo cellular 
microenvironment in three- dimensional models. All the above studies show the cells grown 
as 3D resemble closely to the cells in the in vivo tumors. Thus, we do not expect any potential 
limitations in the clinical translation of the results that are arrived using 3D models. The 
objective of this study is to develop a methodology for identifying VOCs signature of in vitro 
3D models of cells lines. In this study, we analyzed and compared the volatile signatures of 
the primary melanoma cells (WM115) grown as conventional 2D models and 3D models.  
 
4.2. Methods and materials: 
4.2.1. Cell culture: 
In this study, WM-115 (Human primary melanoma) cells were purchased from American 
Type Culture Collection (ATCC), USA. These cells were cultured in Eagle's modified 
essential medium (EMEM) with 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin. All the experiments were carried out in triplicates along with control 
group that was devoid of cells.   
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4.2.2. Three-dimensional cancer model: 
We developed 3D models of primary melanoma cells using hydrogel matrices. We used 
agarose as the hydrogel as it is non-cytotoxic and provides a mesh-like structure that 
simulates the extracellular matrix (ECM). We developed two types of 3D in vitro melanoma 
model: (1) Cells suspended in agarose matrix and (2) Spheroids suspended in the agarose 
matrix. As there are two different ways to generate in vitro 3D cancer models. We intend to 
analyze and compare the volatile signatures of these two types of 3D tumor models. The WM 
115 cells were grown in the 2D until it reaches 95% confluence and harvested. The harvested 
cells were diluted to 1 x 107 cells/mL in various concentrations of agarose (0.5%, 1.0% and 
2.0%). For each sample, 500µL of the aliquot is drawn and poured into the 3D printed mold 
for the agarose matrix formation. The mold has five wells with each well capable of holding 
100µL (Figure 4.1). Once the agarose molds are gelled they are fed with the 50mL of fresh 
medium in the T75 flask and the caps and the vent were sealed using parafilm tape. The 
sealed flasks are incubated at 37°C and 5% of CO2 for five days. 
 
Figure 4.1: 3D printed mold to make agarose matrices for the 3D models.  
 
For the spheroids based model, the harvested 2D cultured cells are diluted to 1 x 107 
cells/mL. For each sample 500µL of the aliquot is drawn and further diluted to 2.5 x 106 
cells/mL. This diluted cell suspension is placed on the lid of the Petri dish in droplets of 10µL 
each. 10mL of Dulbecco's phosphate buffered solution is poured into the Petri dish to make 
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the hydration chamber to prevent the dehydration of the droplets. The lid is gently flipped 
and placed over the Petri dish, which creates the hanging drops due to gravity [107]. The 
Petri dishes were incubated for three days, and the spheroids were harvested and suspended 
in various concentrations of agarose (0.5%, 1.0%, 1.5% and 2.0%) and poured in the 3D 
printed mold for curing and gelation (Figure 4.1). Once the agarose molds are gelled, they are 
fed with the 50mL of fresh medium in the T75 flask and the caps and sealed using parafilm 
tape. The sealed flasks are incubated at 37°C and 5% of CO2 for five days which is followed 
by the VOC analysis. The incubated cells were histologically stained with modified Mason 
trichrome stain for nucleus and collagen then imaged in a light microscope (Figure 4.3). 
 
Figure 4.2: Experimental Methodology. 
4.2.3. Solid Phase Micro-Extraction (SPME) sampling: 
Solid-phase microextraction of the VOCs was performed using the CUSTODION® SPME 
Syringe, StableFlex needle, 23 GA with DVB/PDMS fiber (Torion Technologies Inc. USA). 
The DVB/PDMS fiber was carefully placed in the atmosphere of the culture vessel for 40 
minutes 37°C and 5% of CO2. After incubation, the fiber was carefully retracted into the 
syringe and taken out from the culture atmosphere. The VOC metabolites were then 
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identified using gas chromatography and mass spectrometry (GCMS) (Figure 4.2). 
 
4.3.4. Gas chromatography and mass spectrometry (GCMS): 
The VOC metabolites were identified using gas chromatography and mass spectrometry 
(Shimadzu GCMS-QP2010 Plus system, Japan, with a 0.25 mm x 30 m DB-5MS column that 
had a 0.25um phase film thickness). The SPME syringe needle was inserted into the GCMS 
injection port, in which the cotton wool is removed, and the fiber was extended for 10 
minutes to allow for desorption of the VOC metabolites. Helium carrier gas was maintained 
at a flow rate of 1.0 mL/min. The initial GC oven temperature of 60°C was held for 2 
minutes, followed by a temperature ramp of 8°C per minute up to 200°C followed by the 
second ramp of 5°C per minute up to 260°C then a final ramp of 10°C per minute up to 
270°C which was held for 5 minutes. The mass spectrometer transfer line was maintained at 
280°C, and the source temperature is 230°C. Mass spectra were repeatedly scanned from 20-
700 m/z. The acquired mass spectrum was matched with the mass spectrums of the National 
Institute of Standards and Technology (NIST) MS spectral library and the mass spectrums 
NIST 08 mass spectral database, National Institute of Standards and Technology, 
Washington, DC, USA. The following quasi-linear equation for temperature-programmed 
retention indices was used to confirm the compound identification. 
RIx = [(tx − tn)/ (tn+1 − tn)]100 +100n 
where RIx is the temperature-programmed retention index of interest and tn, tn+1, tx the 
retention time in minutes of the two standard n-alkanes containing n and n + 1 carbons and 





4.3.1. 1% Agarose is the optimum matrix concentration for the development of 3D 
models of primary melanoma: 
In 3D models of primary melanoma, cells and spheroids suspended in agarose were cultured 
for five days under standard conditions. After the incubation, the cells were fixed in 4.5% 
paraformaldehyde, and histology was performed using modified Mason trichrome stain. Our 
histological results clearly showed that in both 3D models, cell proliferation was much better 
in 1% agarose matrices compared to the 0.5% and 2% agarose matrices (Figure 4.3). These 
observations suggested that 1% agarose is the optimal concentration for the development of 
primary melanoma 3D models. In 0.5% agarose matrices, the cells might not get proper 
physical cues as the pore in the agarose matrices will be larger. On the other hand, in the 2% 
agarose matrix, the cells might have suffered from space constriction due to the small pore 
size, which may have restricted the cell proliferation. Hence, all the subsequent results have 
been obtained from the 3D models developed using 1% agarose. 
 
Figure 4.3: Modified mason trichrome staining of the 3D models- Cell suspended in agarose 
model: A- 0.5% agarose; B- 1% agarose; C- 2% agarose. Spheroids suspended in agarose 
model: D- 0.5% agarose; E- 1% agarose; F- 2% agarose. 
 
4.3.2. VOCs signature for primary cells in 2D monolayer culture: 
The GCMS chromatogram of the primary melanoma cells was compared with the negative 
control chromatogram to identify the VOCs produced by the primary melanoma cells. In 
	 71	
general, the chromatograms of both primary melanoma group and the medium control group 
looked very similar with high-intensity peaks, because the VOCs that are emitted by the cells 
were relatively lower in concentration than the background VOCs. We focused only on 
identifying the qualitative VOC biomarkers since qualitative biomarkers are preferred over 
the quantitative biomarkers in the clinical scenario. We were unable to observe any VOC 
biomarker released by the primary melanoma cells (WM115), but we found that these cells 
consume 1-tridecanol. 
 
4.3.3. VOC signatures for primary melanoma 3D models: 
From this study, we observed that the cells suspended in agarose and spheroids (micro tissue) 
suspended in agarose showed very similar VOC signatures. We noted that the two model 
showed differences in the consumption but not in VOC emission. We could also found that 
the concentration of the VOCs emitted by the cell suspended in agarose model is higher than 
the concentration of the VOCs emitted by the spheroids suspended in agarose model. This 
could be because of their difference in the proliferating cell number i.e., In the individual 
cells suspended in agarose model the individual cells are proliferating whereas in the 
spheroids suspended in agarose model the cells at the periphery are the proliferating cells 
whereas the cells at the core of the spheroids are not proliferating as a result of intra-
spheroidal heterogeneity. The differences in the proliferating cell number may be the reason 
for the concentration drop in the VOCs of spheroids suspended in agarose model.  
 
4.4. Discussion: 
4.4.1. VOC profiles of the primary melanoma 2D models are different from 3D models: 
As the number of cells in 2D culture and 3D culture were not the same, it does not make 
sense to compare them quantitatively. But, the qualitative comparison the VOC signatures of 
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the primary melanoma cells in 2D and 3D cultures makes sense. Hence, in this study, we 
focused on the qualitative differences in the VOC signatures. In the 2D models, the primary 
melanoma cells consume 1-tridecanol and do not release any VOCs, whereas the 3D models 
release 4-nonanol, 2-ethyl-1-dodecanol, and 3-tetradecanyl butyrate and consume cinnamic 
acid, 2,4-diaminotoluene, and 1-tetradecene. These results suggest that the VOC signatures of 
the cell lines would differ between 2D and 3D models, which supports our hypothesis. As 3D 
models are the closer replication of the in vivo cells than the 2D models, results observed in 
the 3D models would be relevant for the clinical translation of VOCs based biomarker studies 
[88-90, 146-147]. 
 
4.4.2. Both 3D models exhibit similar VOC signatures: 
The VOCs released by both 3D primary melanoma models were very similar. We observed 
13 peaks that differ qualitatively from the control chromatogram. Among these 13 peaks, 
three peaks were assigned to the compounds namely 4-nonanol, 2-Ethyl-1-dodecanol and 3-
Tetradecanyl butyrate (Table 4.1).  
 
 















































































Table 4.1: Volatile signatures of the 3D models of primary melanoma cells (WM115). 
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Other ten peaks were not assigned as we cannot match similarity hits with the existing 
retention index databases (Table 4.2). These results suggest that the direct cell-cell contact 
does not play any role in the VOC signature of the primary melanoma cell line. However, the 
specific metabolic pathway and biological function of these VOC signatures of primary 
melanoma cells, 4-nonanol, 2-Ethyl-1-dodecanol and 3-Tetradecanyl butyrate are not yet 
known. But it is certain that the presence of these compounds is likely attributed to cellular 
metabolism. It is reported that nonanol exposure could promote cancer cell invasiveness and 
metastases by stimulating the olfactory receptors. Moreover, nonanol serves as an agonist for 
the olfactory receptor OR1G1 and increases the invasion index of the 3D cultured OR1G1 
expressing BON cells (Embryonic carcinoma cell line) [156]. These prior studies suggested 
that primary melanoma cells in 3D models may release 4-nonanol as a signaling molecule to 
promote invasion. VOCs could act as chemical messengers that could alter the gene 
expression of the exposed cells. Prior studies show that the VOCs exposure affects the 
expression of GRP78, which could result in the accumulation of the misfolded and under-
glycosylated proteins in the endoplasmic reticulum [157]. This further suggests that VOCs 
may act as chemical messengers. 





1 16.442 1592.80 27,41,45,55,56,67,71,85,87,97,98,105,111,119, 
124,143. 
2 16.875 1622.66 27,43,55,56,71,73,87,115,233. 
3 16.975 1629.64 27,43,45,55,57,71,77,85,87,97,99,105,115,129. 
4 17.908 1695.26 27,43,45,55,56,71,85,87,99. 
5 18.617 1746.61 27,43,55,71,98. 
6 18.867 1765.02 27,31,41,43,55,58,71. 
7 19.492 1810.23 31,43,55,71,98,111,116,143. 
8 20.292 1864.80 27,31,41,43,55,71,85,101. 
9 20.425 1873.87 28,43,45,55,56,73,74,85,89,103,116,143 
10 21.358 1928.81 31,43,45,66,56,71,85,89,101,117,143 
Table 4.2: Unidentified Volatile signatures of primary melanoma cells (WM115) that are 
common for both 3D models. 
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4.4.3. Direct cell to cell contact does not play a role is VOCs release: 
In the cells suspended in agarose model, all the single cells were grown in the 3D agarose 
mesh without direct cell-cell contact. The gradients of nutrition, CO2, O2, and wastes were 
maintained by the agarose matrix, i.e., the cells suspended in the periphery of the agarose 
matrix have higher accessibility to the resources than the cells in the core of the agarose 
matrix. In the spheroids suspended in agarose model, the cells were cultured in the three-
dimensional agarose matrix with direct cell-cell contact. Similarly, the gradients were 
maintained within the spheroids, where the cells on the outer surface of the spheroids have 
higher accessibility to the resources than the cells in the core of the spheroids [88]. This study 
has demonstrated the process of obtaining VOC signatures of the 3D models of the primary 
melanoma cell line. We have deciphered the VOC signatures of the two possible hydrogel-
based 3D models were similar to each other. This observation suggested that direct cell-to-
cell contact does not play a role in VOCs release. 
 
4.5. Conclusion: 
In this study, we have demonstrated a novel method for the identification of the VOC 
signature of the cell lines using 3D models. We have shown that the VOC signatures of the 
2D models were different from the 3D models. We have developed two types of 3D models 
and evaluated their VOC signatures.  Moreover, we found that the VOC signatures of both 
the 3D models were very similar, which suggests that direct cell-cell contact does not play 
any role in the VOC signature, providing an insight that these released VOCs could function 
as intercellular signals. As 3D cell culture models are the closer replica of the in vivo cells 
than 2D models, the VOC signature results of the 3D cell culture models would be more 




Identification of volatile signatures of cancer cells forms the basis for volatile-based cancer 
diagnosis and also for deciphering their unexplored volatile metabolism. All prior research in 
this area of volatile profiling is based on 2D-cultured cell lines, which drastically vary from 
the in-vivo cells, thus limiting the clinical translation of these studies. Previous studies 
indicated that culturing cells in 3D architecture mimic that of the in-vivo cells.  In this study, 
we have developed 3D models of primary melanoma cells (WM115) and compared their 
volatile signatures with the volatile signatures of their corresponding 2D models. The two 
types of 3D models are 1) cells suspended in agarose matrix and 2) spheroids/micro-tissues 
suspended in the agarose matrix. We have found that the volatile signatures of the 2D and 3D 
cultured primary melanoma cells were completely different. Moreover, we have also 
observed that there were no differences in the volatile emission between the two types of 3D 
models as both 3D models released the same 13 compounds (3 identified and 10 
unidentified). However, cells suspended in agarose model consumed 2 additional volatile 
organic compounds (VOCs) compared to the spheroids suspended in agarose model. Our 
results suggest that volatile signatures do not play a role in cell-cell contact, providing insight 
that they may act as signaling molecules. All the current literature addressing the VOC-based 
characterization of the cells shows the VOC biomarkers of a particular condition but does not 
link VOCs with a distinct phenotype.  These results encouraged to study whether VOCs play 
a role in intercellular signaling in response to changes in the cellular microenvironment such 









Cellular level quorum sensing is manifested by release of volatile 





Quorum sensing (QS) is an interesting cell to cell communication phenomenon first observed 
in the marine bacterium Vibrio fischeri, where QS regulates bioluminescence [186]. Quorum 
sensing helps in the intraspecies or interspecies bacterial communication mediated by the 
chemical messengers known as autoinducers, secreted by the bacterial cells in a cell density-
dependent manner. These secreted chemical messengers are related to cell density or as a 
metabolite indicating different growth stages of the bacteria [159,160]. Apart from 
bioluminescence, quorum sensing plays a pivotal role in sporulation (Micrococcus gezantuse) 
, Conjugation (Enterococcus fecalis), differentiated morphology (Streptomyces Cuiceilar), 
regulating gene expression in response to abiotic factors (Vibrio cholera), biofilm formation 
(Pseudomonas aeruginosa where QS controls over 600 genes), production of extracellular 
toxic proteins (Enterococcus, Bacillus, Streptococcus, Streptomyces and Staphylococcus), 
regulation of virulence factor synthesis (Pseudomonas, Brucella, Erwinia, Ralstonia, Vibrio, 
Agrobacterium, Enterobacter, Serratia, Yersinia, Burkholderia and Vibrio.), nitrogen 
fixation (Rhizobium genus) etc., [161,162].  
It seems that QS is conserved across different domains of life as this phenomenon was 
recently observed in eukaryotic unicellular organism Candida albicans, where the quorum 
sensing molecule(QSM) is identified as farnesol [163]. Later, more molecules like aromatic 
alcohols, tyrosol, dodecanol, ɣ-butyrolactone, or ɣ-heptalactone have been reported as the 
QSM [164]. QS can be used as the mode of communication between different species and 
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even between different kingdoms of life. There are studies deciphering QS based 
communication between bacteria and fungi, fungi and plant hosts as well as mammalian 
hosts. In a very interesting study, it was shown that the C. albicans produced QSM that could 
attract leukocytes [165]. These studies hinted that even mammalian cells are compliant with 
the QS. 
A recent study documented the role of organ level quorum sensing in the hair follicle 
regeneration in response to hair plucking mediated by chemokine (C-C motif) ligand 2 
(CCL2). CCL2 promote hair follicle regeneration by attracting and recruiting TNF- α 
positive macrophages [166]. These studies motivated us to seek for the existence of quorum 
sensing in human cells. Due to the lack of readily observable phenotype like virulence, 
biofilm, bioluminescence, etc., in the human cells, makes the identification of cellular level 
quorum sensing very challenging. Fortunately, most of the human cells produce volatile 
organic compounds as indicators of their physiological and pathological status [148-154]. 
Another reason for selecting volatile organic compounds as our method of phenotyping is 
that VOCs production is conserved in all the domains of life ranging from bacteria to human 
cells [167 and references therein].  
The objective of this study is to investigate the existence of quorum sensing in mammalian 
cells. We hypothesize that cell density based cell signaling, i.e., QS can be observed using the 
VOCs production of these cells. In this study, we used human metastatic melanoma cells 
(WM266) and cultured them in 3D architecture using hydrogel matrices at different cell 
densities. Even though the cell density is different, we maintained the total number of cells 




5.2. Methods and Materials: 
5.2.1. Cell culture: 
For this study, WM-266 (human metastatic melanoma) cells were purchased from American 
Type Culture Collection (ATCC), USA. These cells were cultured in Eagle's modified 
essential medium (EMEM) with 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin. We used agarose as the hydrogel as it is non-cytotoxic and provides 
a mesh-like structure that simulates the extracellular matrix (ECM).  
The WM 266 cells were grown in the 2D culture until it reaches 95% confluence and 
harvested by trypsinization. The harvested cells were diluted into 4 different concentrations 
such as 1 x 106 cells/mL, 2 x 106 cells/mL, 5 x 106 cells/mL and 10 x 106 cells/mL in 1.0% 
agarose. From each concentration 2 x 106 cells were drawn and poured in the 3D printed 
mold for curing and matrix bead formation (bead dimension: 10mmX5mmX2mm) i.e., 2mL 
from 1 x 106 cells/mL aliquot, 1mL from 2 x 106 cells/mL aliquot, 0.4 mL in 5 x 106 cells/mL 
aliquot and 0.2mL from 10 x 106 cells/mL aliquot. A single mold can form 5 agarose beads as 
they have 5 wells with each well capable of holding 100µL. Once the agarose molds were 
gelled, they were fed with the 35mL of fresh medium in the T75 flask. The sealed flasks were 
incubated at 37°C and 5% of CO2 for 5 days.  
Thus cell density in each agarose pellet will be different (1 x 105 cells/ agarose pellet, 2 x 105 
cells/ agarose pellet, 5 x 105 cells / agarose pellet and 10 x 105 cells / agarose pellet in 1 x 106 
cells/mL, 2 x 106 cells/mL, 5 x 106 cells/mL and 10 x 106 cells/mL samples respectively) but 
total number of cells seeded will remain constant across all the samples (Figure 5.1). All the 
experiments were carried out in triplicates along with control group, which was devoid of 
cells. After five days of incubation, the spent nutrient medium is collected and saved in the 




Figure 5.1: Research methodology followed in this study 
5.2.2. Sample Preparation: 
In in vivo, the volatiles produced by the cells tend to dissolve in blood and excreted during 
exhalation as a result of gaseous exchange in lungs. In vitro, the volatiles generated by the 
cells tend to dissolve in the nutrient medium. As gaseous exchange is not possible in in vitro 
condition, a reliable method of separating the volatiles dissolved in the spent nutrient medium 
is needed for the volatile analysis. We opted for salting out method using NaCl [167]. The 
preserved spent nutrient medium was thawed at room temperature. From the thawed spent 
nutrient medium 5 mL was drawn to the 60mL tube that contains 1 gram of NaCl (20%). The 
tube was then sealed with a stopper containing PFTE septa. The NaCl salt was dissolved in 
the medium by gentle agitation which results in the release of dissolved volatiles to the 
headspace of the 60 mL tube, as the solubility of NaCl is higher than the VOCs. The tubes 
were incubated for at least 2 hours in room temperature before volatile analysis for achieving 
equilibration. 
5.2.3. Volatile Analysis Using SIFT-MS and Statistical Analysis: 
The headspace volatiles of the equilibrated tubes was fed into the SIFT-MS (Voice 2000, 
New Zealand) at the rate of 25 standard cubic centimeters (sccm) using an 18-gauge needle. 
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A full mass scan (M/Z range: 18 – 200) was performed with three reaction ions namely H3O+, 
NO+ and O2+. The M/Z ratios and their corresponding counts were collected. For the 
convenience of data comparison, all the samples were analyzed on the same day one after the 
other. All the statistical analysis was performed by the MetaboAnalyst 3.0, online statistical 
software (www.Metaboanalyst.ca/, Canada) [54]. The collected M/Z ratios with their counts 
were converted into single concatenated vector in order make it compatible for the 
MetaboAnalyst 3.0. The product ion count rate depends on the precursor ion count rate which 
varies from day to day; we conducted a normalization procedure in which product count rates 
of each sample were divided by corresponding H3O+, NO+, and O2+ precursor count rates 
[168]. Statistical methods, such as heat map analysis of the significant product ion M/Z 
ratios, clustering analysis, t-test, etc., were performed using MetaboAnalyst 3.0 after 
logarithmic normalization and auto scaling. All the significant M/Z ratios mentioned in this 
article were having p-value lesser than 0.05. The ions comprise precursor, isotopologues and 
water clusters their isotopologues were removed as the precursors were carrier ions added to 
the sample, they need to be deleted from H3O+ product ion list. Hence, the M/Z of 19, 20, 21, 
30, 32, 37, 38, 39, 55, 56, 57, 73, 74, 75, 91 in H3O+ were removed. Further M/Z in NO+ 
product ions including 19, 30, 32, 37, 48, 50, 55, 57, 66, 73, 91, are removed and 19, 30, 32, 
33, 34, 37, 50, 55, 56, 57, 73, from the O2
+ product ion list [169]. However, the 
isotopologues that are highly significant (p-value <0.01) in t-test were retained. The 
compounds were predicted using the inbuilt database developed from various detailed 
selected ion flow tube (SIFT) studies of different classes of compounds (alcohols, aldehydes, 




5.3. Results and discussion: 
5.3.1. Statistical analysis of the SIFT-MS data: 
Full mass scan SIFT–MS data obtained for the four cell density groups and statistically 
compared with the corresponding controls using Student T-test. The number of significant (p. 
value < 0.05) product ion M/Z ratios were found to be varying with the cell density (Table 











Figure 5.2: Heat Maps and clustering analysis of SIFT-MS product ion data of WM266 cells 
at various cell density. A- 1 x 106 cells/mL of 1% agarose; B- 2 x 106 cells/mL of 1% 












Table 5.1. List of all the significant (p-value <0.05) product ion M/Z ratios at different cell 
density representing the VOCs released and consumed by the WM266 (metastatic melanoma 
cells. 
 
 We observed that the number of significant M/Z ratios representing the VOCs released 
increases with the increase in cell density whereas the significant M/Z ratios representing the 







Statistically significant product ion 
M/Z (P-Value <0.05) 
Representing the VOCs released by 
the cells 
Statistically significant product ion 
M/Z (P-Value <0.05) 
Representing the VOCs consumed 
by the cells 
1 x 106 H3O+  33, 43, 45, 51, 71, 72, 76, 80, 86, 87, 
88, 90, 94, 101, 108, 113, 117, 120, 
129, 132, 139, 149, 159, 163, 167.  
NO+  43, 60, 62, 71, 83, 85, 89, 99, 100, 104, 
105, 118, 126, 143.  
O2+  18, 62, 69, 71, 74, 76, 80, 90, 92, 99, 
100, 111, 115, 120, 134, 159. 
2 x 106 H3O+ 143, 144, 82 46, 72, 102, 107. 
NO+ 136, 148  
O2+ 94 43, 49, 74, 76, 82, 104, 106, 117. 
5 x 106 H3O+ 29, 35, 36, 58, 60, 61, 68, 71, 81, 85, 
86, 89, 96, 103, 113, 115, 117, 121, 
147. 
 
NO+ 36, 56, 58, 69, 71, 83, 84, 86, 87, 101, 
102, 104, 114, 115, 118, 126, 127, 129, 
130, 144, 151. 
51, 71, 85, 113, 126, 138, 199. 
O2+ 17, 35, 41, 42, 43, 48, 59, 60, 69, 70, 
71, 74, 75, 77, 80, 84, 85, 87, 88, 89, 
92, 99, 103, 117, 191, 196.   
54, 173. 
10 x 106 H3O+ 58, 60, 67, 69, 70, 76, 85, 89, 93, 103, 
149, 187. 
123, 145. 
NO+ 47, 56, 58, 63, 83, 84, 86, 87, 90, 101, 
104, 108, 112, 114, 136, 139. 
 





Figure 5.3. Number of Significant product ion M/Z representing the VOCs released and 
consumed by the cells at various cell densities  
 
Likely that the WM266 cells consumed more VOCs at lower cell densities and when the cell 
density increases they releases more VOCs consuming fewer VOCs. Initially, this 
observation made us propose a hypothesis that the increase in cell density causes scarcity of 
the nutrients especially to the cells located at the core of the agarose matrix, causing the cell 
to undergo apoptosis and the VOCs we observed could be the indicator or the by-product of 
apoptosis. To validate this hypothesis, we performed histological analysis of the agarose 
matrices (that are previously fixed in 4.5% paraformaldehyde immediately after incubation) 
at three different depths namely at the outermost region, innermost region and in between 













































Figure 5.4: Histology of the agarose matrix containing WM266 cells at different cell 
densities on 5th of incubation, showing that the cell proliferation is not affected across the 
agarose matrix (Scale = 200µm).  
The H&E staining of these slices clearly shows that cell proliferation is not constrained due 
to the increase in the cell density as we could observe active cell proliferation at all the three 
depths in all studied cell densities. Hence the significant product ion M/Z ratios we observed 
can be attributed solely to the increase in cell density rather than apoptosis or cell death.  This 
observation is the clear indication that these cells alter their volatilome based on the cell 
density and provide insight about the existence of cellular level quorum sensing in these cells.   
5.3.2. Volatiles could be the phenotypic manifestation of quorum sensing in metastatic 
melanoma cells: 
Among the significant (p-value<0.05) product ion M/Z ratios, we could observe 29 M/Z 
ratios were present in both 5 x 106 cells/mL and 10 x 106 cells/mL groups and all these M/Z 
were highly significant (p-value<0.01) compared to their corresponding controls (Table 5.2).  
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Table 5.2. List of the 29 highly significant (p-value < 0.01) product ion M/Z ratios, 
representing the VOCs released by the WM266 (metastatic melanoma cells that are observed 
in both at 5 x 106 and 10 x 106 cell densities. 
 
Hence clearly these 29 M/Z ratios were the manifestation of the quorum sensing in WM 266 
cells. We have identified 10 compounds using the inbuilt SIFT-MS library matches based on 
these 29 M/Z ratios (Table 5.3).  










Product ions Branching 
ratio 
1 2-hexene H30+ 2.0E-9 85 C6H13+ 1 
NO+ 1.9E-9 84 C6H12+ 0.55 




H30+ 3.0E-9 89 C5H12O.H+ 0.4 
57 C4H9+ 0.6 
NO+ 2.4E-9 86 C4H8.NO+ 0.1 
57 C4H9+ 0.9 
O2+ 3.0E-9 89 C5H13O+ 0.05 
73 C4H9O+ 0.75 
57 C4H9+ 0.2 
3 Dipropenyl 
sulfide 
NO+ 2.5E-9 114 (C3H5)2S+ 1 
4 Propanoic 
acid 
H30+ 2.7E-9 57 C2H5C0+ 0.05 
75 C2H5COOH2+ 0.95 
NO+ 1.5E-9 57 C2H5CO+ 0.05 
104 NO+.C2H5COOH 0.95 
O2+ 2.2E-9 74 C3H5COOH+ 1 





Statistically significant product ion M/Z (P-Value <0.05) 
Representing the VOCs released by the cells 
5 x 106 and 10 x 
106 
H3O+ 57, 58, 60, 75, 85, 89, 103. 
NO+  56, 57, 58, 73, 83, 84, 86, 87, 101. 104, 114. 
O2+ 41, 42, 56, 57, 59, 74, 75, 77, 87, 89, 101. 
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2-butanol NO+ 2.5E-9 101 C6H13O+ 0.9 
85 C6H13+ 0.1 
O2+ 1.9E-9 87 C5H11O+ 0.2 
57 C4H9+ 0.35 
56 C4H8+ 0.3 
45 C2H5O+ 0.15 
6 Isobutene NO+ 1.5E-9 86 NO+.C4H8 0.15 
56 C4H8+ 0.85 
7 2-butene H30+ 1.6E-9 57 C4H9+ 1 
NO+ 1.3E-9 56 C4H8+ 1 
O2+ 1.4E-9 41 C3H5+ 0.5 
56 C4H8+ 0.5 
8 1-hexene H30+ 2.1E-9 85 C6H13+ 1 
NO+ 1.8E-9 86 C4H8.NO+ 0.35 
114 C6H12.NO+ 0.25 
46 CH4.N0+ 0.15 
72 NO+.C3H6 0.1 
69 C5H9+ 0.1 
83 C6H11+ 0.05 
9 2-methyl-2-
propanol 
H30+ 2.7E-9 57 C4H9+ 1 
NO+ 2.0E-9 57 C4H9+ 1 
O2+ 2.1E-9 59 C3H7O+ 1 
10 Butyl 
hexanoate 
H30+ 3.0E-9 57 C4H9+ 1 
NO+ 3.0E-9 73 C4H9O+ 1 
O2+ 2.0E-9 59 C3H7O+ 0.4 
56 C4H8+ 0.6 
 
Table 5.3: List of identified VOCs released by WM266 (metastatic melanoma) cells at 5 x 




Due to the lack of studies relating the volatile metabolites with the cellular physiology, it is 
very hard to understand the precise role of these VOCs in cellular biology. Among these 
predicted compounds methyl tertiary butyl ether and isobutene has been reported as volatile 
biomarkers for lung cancer cell line called A549 and interestingly isobutene is observed only 
in the higher A549 cell concentration as a qualitative biomarker. This study is noteworthy 
here because in that study higher cell concentration means higher cell density as the various 
cell concentrations were cultured in cell culture bottles of same dimensions, which supports 
the results of our study [171].  2-butene has already reported as a VOC of normal human 
breath [172]. 1-hexene has been identified as the lung cancer-associated biomarker using 
discriminant analysis of the GC-MS data and using sensors made of carbon nanotube coated 
with non-polymeric organic materials [173,174].  2-methyl-2-propanol has been observed to 
be released only by the normal lung cells and not by the transformed cells [208], but our 
results suggest that this might not be true with melanoma. It is also important to note that, all 
the existing cell line studies in the scientific literature were based on the 2D cultured cells. 
We adopted 3D culture as 3D cultured cells were very much similar to the in vivo cells as 
they showed all the characteristic features of in vivo cells [88-91, 146-147]. 
5.3.3. Quorum sensing model: 
By these results, we propose the following quorum sensing model for the metastatic 
melanoma cells. Metastatic melanoma cells tend to secrete the quorum sensing molecule 
(QSM). When the QSM reaches a threshold limit, which is corresponding to the cell number, 
these cells release of specific VOCs that may act as cell signaling molecules (Figure 5.5). 
This hypothesis is possible as there are reports showing VOCs were capable of altering gene 
expression.  In a recent study, VOCs exposure affects the expression of GRP78, which could 
result in the accumulation of the misfolded and under-glycosylated proteins in the 
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endoplasmic reticulum [157]. Previous studies on bacterial VOCs also claimed that volatile 
produced by bacteria helped in enhancing growth in many plants by modulating various 
genes [175-177]. The QSM might not be a VOC because we could not observe any consistent 
release of VOCs that are released by all the cell density groups. Thus clearly VOCs could not 
be a QSM at least for WM266 cells.   
 
Figure 5.5: Proposed quorum sensing model   
 
5.3.4. Clinical significance of cellular quorum sensing: 
The clinical significance of cellular level quorum sensing is very high especially in the case 
of complex diseases like cancer. Once the quorum sensing molecule (QSM) of the cancer 
cells has been identified, we can target the QSM to neutralize it. So that, the progression of 
cancer cells could be restricted. This approach could open up novel treatment strategy in the 




The significant product ion M/Z ratios obtained from the statistical analysis of the SIFT–MS 
data at higher cell density is highly significant and consistent. This study suggested the 
existence of the cellular level quorum sensing in the WM266 cells. According to the best of 
our knowledge, this is the first study to show the existence of cellular level quorum sensing in 
mammalian cells. We have also included the histological study to validate the existence of 
cellular level quorum sensing in WM266. We have also proposed a quorum sensing model 
and its probable role in VOCs based cell signaling. 
 
5.5. Summary: 
Quorum sensing is a cell to cell communication phenomenon, which was observed and 
extensively studied in various bacterial species. In the mammalian cells, it is very hard to 
observe quorum sensing as they lack in phenotypes, which can be observed without 
disturbing the cells. We have investigated the metastatic melanoma cells (WM266) for the 
existence of cellular level quorum sensing by observing the alteration in the cell's volatile 
organic compounds (VOCs) emission profiles. We had developed a series of 3D models with 
different cell densities while maintaining a constant number of cells. We extracted VOCs 
from the spent medium by salting out procedure. These extracted VOCs were analyzed using 
SIFT-MS full mass scan mode. Our study showed that, when the cell density was increased, 
the metastatic melanoma cells released characteristic VOCs. This finding proved that the 
metastatic melanoma cells could sense the cell density in their vicinity and respond to it by 
emitting certain VOCs, suggesting the existence of cellular level quorum sensing. Clinically, 
once the molecule responsible for the quorum sensing is identified, we can control cancer 
progression by neutralizing the quorum sensing molecule. The next step is to focus on gastric 
cancer and find out, is it possible to identify gastric cancer using their VOC signatures and 
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also to observe the dynamics of these VOC signatures in response to the anti-cancer 















































Volatile Biomarkers and Curcumin-Induced Volatile Signatures 




Gastric cancer ranks as the third fatal cancer with 0.72 million deaths worldwide in 2012, and 
according to the World Health Organization, the highest incidence of gastric cancer is 
observed in the Asia-Pacific region, especially in Japan. Two important aspects of cancer 
research are diagnosing cancer and monitoring cancer treatment [1]. The gold standard for 
the diagnosis of gastric cancer is esophagogastroduodenoscopy (EGD) and biopsy. Although 
these invasive methods are widely accepted, they still create significant discomfort for the 
patients especially in children and elderly with potential complications such as perforation 
and aspiration if handled by poor operators. Furthermore, these are not cost-effective as 
screening tools. It is imperative to develop a non-invasive and cost effective gastric cancer 
diagnosing tool. Fortunately, most of the human cells produce volatile organic compounds as 
indicators of their physiological and pathological status [181, 88 - 91, 146-147]. This study 
aims to identify the volatile signatures of the gastric cancer cells, as our first to develop 
volatile based gastric cancer detection method. Cellular level volatile profiles might be useful 
to understand gastric cancer biology in the perspective of volatile metabolites.  
Turmeric (Curcuma longa) is a spice containing the following ingredients; curcumin, 
dimethoxy curcumin, bisdemethoxycurcumin curcumin, and cyclo curcumin [178]. The 
antioxidant properties of these curcumins are attributed to the hydroxyl group whereas the 
anti-proliferative property is attributed to the methoxy groups [179]. Curcumin has been 
found to inhibit the signaling pathways of cancer cells, inhibit cell proliferation, invasion, 
angiogenesis, and metastasis. In the prospect as a chemo-protectant against cancer, Curcumin 
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is very promising as it can induce apoptosis by several molecular pathways. These pathways 
include and are not limited to activation of caspase, induction of death receptors, aggregation 
of Fas receptor, induction of p53/p21 pathway, release of apoptosis inducing factor, 
regulation of cell cycle,  down-regulation of androgen receptors, activation of thioredoxin 
reductase, activation of c-Jun Kinase, induction of DNA fragmentation, depletion of 
intracellular Ca2+, activation of mitochondrial activation, suppression of anti-apoptotic 
proteins, binding to microtubules, activation of proteasome, pro and antioxidant mechanisms, 
autophagy and inhibition of various cancer-related genes and gene products such as PI3K-
AKT, mTOR, AMPK, COX2, 5 LOX, hTERT, STAT3, NF-κB, Wnt/beta-catenin signaling, 
growth factors and their receptors, ornithine decarboxylase, acidic sphingomyelinase, 
phospholipase D, glyoxalase etc. [180].   
The objectives of this study are to identify the VOCs biomarker for gastric cancer spheroids 
and to investigate the alteration in the VOCs signature of gastric cancer spheroids in response 
to curcumin treatment. In this study, we hypothesize that gastric cancer cell lines have unique 
volatile signatures and these volatile signatures would change in response to the curcumin 
treatment. We examined four gastric cancer cells lines (SNU 484, IST 1, MKN 28, NUGC 3) 
and one normal gastric cell line (HS 738), for the identification of gastric cancer-specific 
volatile biomarkers. From these identified volatile compounds, biomarkers of the gastric 
cancer spheroids were deduced. We treated the above mentioned multicellular spheroids with 
curcumin and identified the volatile compounds produced by these spheroids in response to 
curcumin treatment. Our results suggest that the curcumin treatment triggers either the 
production of curcumin associated cell death related volatiles (as in SNU 484 and NUGC 3) 
or curcumin associated cell death evasion related volatiles (as in MKN 28, IST 1 and HS 
738).   
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6.2. Methods and Materials: 
6.2.1. Cell Culture: 
Four gastric adenocarcinoma cell lines SNU484, MKN28, IST1, and NUGC3 and a normal 
cell line HS738 were used in this study. The gastric adenocarcinoma cells were cultured in 
Roswell Park Memorial Institute (RPMI) medium with 10% fetal bovine serum (FBS), and 
the normal gastric cell line was cultured in Dulbecco's modified essential medium (DMEM) 
with 10% FBS. All the experiments were carried out in triplicates along with the spent 
medium, which served as the background control.  
 
S. No Cell 
Line 





1 SNU484 Adenocarcinoma Primary Poor Stomach Round oval 
2 MKN 28 Tubular 
adenocarcinoma 
Metastatic Moderate Lymph node Polygonal 
3 IST 1 Tubular 
adenocarcinoma 
Metastatic Moderate Liver Polygonal 
4 NUGC 3 Adenocarcinoma Metastatic Poor Brachial muscle Polygonal 




Table 6.1: Characteristics of the gastric cell lines used in this study. 
6.2.2. Formation of Cellular Spheroids: 
For the spheroids formation, the cells were grown as a monolayer (2D culture) and harvested 
using trypsinization. The harvested cells were checked for their viability by dye exclusion 
method using bromophenol blue dye. The samples with required viability (95%) were diluted 
into 2.5x106 cells/mL for spheroid formation.  Each replicate contained 20 mL of the diluted 
cell suspension equivalent to 5X107 cells. The diluted cell samples were drawn into drops of 
10µL on the lid of the sterile petri dish. The petri dish was filled with 10mL of Dulbecco's 
Phosphate-Buffered Saline DPBS which will act as the hydration chamber. The petri dish lid 
was gently inverted and fixed over the petri dish and placed in the incubator for the spheroid 
formation [107]. After incubation for 3 days, the spheroids, observed by the naked eye as 
white spheres, were harvested and cultured in a custom made silanized glass culture flask. 
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The spheroids were further cultured for 6 days with 50mL of RPMI medium with 10% FBS 
with nutrient medium being replaced on every alternative day. On the sixth day, the spheroid 
culture was replaced with RPMI medium with 10% FBS supplemented with 75mg of 95% 
curcumin (100% pharmaceutical grade, Turmeric - Curcumin extract with 95% curcumin, 
21st Century, Singapore). On the eighth day as well as on the tenth day, the spheroid culture 
was replaced with RPMI medium with 10% FBS supplemented with 150mg of 95% 
curcumin. The spheroids were observed under the light microscope on every alternative day 
just before replacing the nutrient medium.   
 
6.2.3. Sample collection and time of sample collection: 
The spent nutrient medium was the sample for this study. 50mL spent medium was collected 
on every alternative day before replacing the culture flask with fresh nutrient medium or 
curcumin supplemented nutrient medium. The collected spent nutrient medium was saved in 
the sterile 50 mL falcon tubes and preserved at -800 C until analysis. 
 
6.2.4. Sample preparation: 
In vivo, the volatiles produced by the cells tend to dissolve in blood and get excreted during 
exhalation as a result of gaseous exchange in lungs. In vitro, the volatiles generated by the 
cells tend to dissolve in the nutrient medium. As gaseous exchange was not possible in vitro, 
a reliable method of salting out method using sodium chloride (NaCl) was used to separate 
the volatiles dissolved in the spent nutrient medium needed for the volatile analysis. The 
preserved spent nutrient medium is thawed to room temperature. From the thawed spent 
nutrient medium, 5 mL was drawn to the 60mL tube that contains 1 gram of NaCl (20% 
W/V). The tube is then sealed with a stopper containing Polytetrafluoroethylene PFTE septa. 
The NaCl salt was dissolved in the medium by gentle agitation which results in the release of 
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dissolved volatile to the headspace as the solvation power of NaCl was higher than that of 
volatile organic compounds VOCs. The tubes were incubated for at least 2 hours before 
volatile analysis for achieving equilibration [154].  
 
6.2.5. Volatile analysis using SIFT-MS and statistical analysis: 
The headspace volatiles of the equilibrated tube were fed into the SIFT-MS at the rate of 
25mL/min using 18-gauge needle. A full mass scan (M/Z range: 18 – 200) was performed 
with three reaction ions namely H3O+, NO+ and O2+. The M/Z ratios and their corresponding 
counts were collected. For the convenience of data comparison, all the samples for a single 
cell line were analyzed on the same day one after the other. All the statistical analysis was 
performed by the MetaboAnalyst 3.0 online statistical software (www.Metaboanalyst.ca/, 
Canada) [54]. The collected M/Z ratios with their counts were formatted in order make it 
compatible for the MetaboAnalyst 3.0 before statistical analysis. We conducted a 
normalization procedure in which product count rates of each sample were divided by 
corresponding H3O+, NO+, and O2+ precursor count rates [168]. Since the product ion count 
rate depended on the precursor ion count rate which varied from day to day, All the 
significant M/Z ratios mentioned in this article were having p-value lesser than 0.05 (Figure 
6.1). The compounds were predicted using the inbuilt database developed from various 
detailed selected ion flow tube (SIFT) studies of different classes of compounds (alcohols, 
aldehydes, ketones, hydrocarbons, etc.) with the three precursor ions mentioned above [170]. 
However, we were not able to identify all the VOCs that are represented by the significant 
M/Z ratios mainly because of the limited number of compounds in the SIFT library, which is 
expected to increase in future. 
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Figure 6.1. The experimental procedure of this study.  
6.3. Results: 
6.3.1. Volatile signatures of gastric cancer cells in monolayer (2D) culture: 
In monolayer culture, we observed that the gastric cancer cells produce many VOCs, which 
was represented by the significant (p-value <0.05) M/Z ratios and the normal gastric cells 
(HS738) showed only 4 significant M/Z ratios (Table 6.2). Among those significant M/Z 
ratios of gastric cancer cells, 68 ratios were found to be observed in all the gastric cancer 
groups. It was also noted that 32 significant M/Z ratios were found to be present only in the 
metastatic gastric cancer groups. These results suggested that, under monolayer culture, VOC 
profiles were capable of classifying, normal gastric cells as well as primary and metastatic 










Product ion M/Z ratios 
HS738 H3O+ 54, 
NO+ 118. 
O2+ 31, 49. 
MKN 
28 
H3O+ 101, 105, 114, 117, 127, 133, 135, 137, 139, 140, 141, 147, 181, 189, 31, 33, 
35, 36, 45, 46, 47, 48, 49, 51, 52, 53, 63, 64, 65, 66, 67, 69, 73, 74, 75, 82, 
83, 84, 85, 89, 91, 92, 93, 94, 95. 
NO+ 102, 109, 110, 113, 116, 118, 121, 123, 128, 130, 132, 137, 139, 147, 158, 
175, 31, 33, 36, 37, 39, 43, 45, 46, 47, 51, 55, 62, 63, 64, 65, 66, 67, 69, 73, 
74, 75, 76, 81, 83, 84, 85, 89, 90, 91, 92, 93, 94. 
O2+ 111, 112, 117, 119, 124, 127, 131, 133, 135, 137, 139, 140, 141, 143, 146, 
147, 169, 175, 189, 191, 18, 19, 30, 31, 33, 36, 37, 39, 41, 43, 44, 45, 46, 47, 
48, 49, 51, 52, 53, 54, 55, 57, 60, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 
74, 75, 76, 77, 78, 81, 82, 83, 84, 85, 86, 88, 89, 90, 91, 92, 93, 94, 95. 
IST 1 H3O+ 101, 103, 104, 105, 113, 114, 117, 127, 128, 129, 135, 139, 143, 147, 149, 
150, 153, 155, 163, 189, 31, 33, 36, 47, 48, 49, 51, 52, 53, 57, 58, 64, 65, 66, 
67, 69, 70, 71, 72, 75, 83, 84, 85, 87, 89, 91, 92, 93, 94, 95. 
NO+ 100, 101, 102, 103, 105, 107, 112, 113, 114, 115, 116, 117, 118, 126, 130, 
132, 133, 141, 142, 144, 147, 154, 156, 158, 36, 37, 43, 45, 46, 47, 51, 54, 
55, 56, 57, 58, 62, 63, 64, 65, 66, 68, 69, 70, 71, 73, 76, 83, 84, 85, 86, 87, 
88, 89, 91, 92, 93, 94, 96. 
O2+ 101, 103, 105, 111, 113, 114, 115, 117, 118, 119, 122, 124, 126, 127, 129, 
131, 135, 139, 141, 143, 145, 147, 173, 191, 18, 19, 30, 31, 33, 36, 41, 43, 
45, 46, 47, 48, 49, 51, 52, 57, 58, 59, 60, 63, 64, 65, 66, 67, 68, 69, 70, 71, 
72, 73, 75, 76, 77, 78, 83, 84, 85, 86, 87, 88, 89, 91, 92, 93, 94, 95. 
SNU 
484 
H3O+ 101, 102, 103, 104, 113, 117, 127, 128, 129, 135, 141, 150, 31, 33, 36, 47, 
49, 51, 52, 53, 57, 58, 60, 69, 70, 71, 75, 83, 85, 87, 89, 93, 94, 99. 
NO+ 101, 102, 103, 112, 113, 114, 115, 116, 118, 123, 126, 128, 130, 132, 141, 
142, 144, 146, 154, 156, 158, 36, 45, 46, 47, 51, 55, 56, 57, 58, 62, 63, 64, 
65, 68, 69, 70, 71, 72, 73, 76, 83, 84, 86, 91, 93, 94. 
O2+ 101, 103, 110, 111, 114, 117, 118, 127, 129, 135, 141, 142, 17, 18, 31, 33, 
35, 36, 41, 47, 49, 51, 52, 57, 59, 60, 65, 66, 68, 69, 70, 71, 72, 75, 76, 77, 
83, 85, 86, 87, 88, 91, 93, 94, 95. 
NUGC 
3 
H3O+ 101, 102, 105, 111, 113, 127, 133, 135, 137, 139, 147, 189, 31, 33, 36, 45, 
46, 47, 48, 49, 51, 52, 53, 60, 63, 64, 65, 66, 67, 69, 75, 83, 84, 85, 91, 92, 
93, 94, 95, 99. 
NO+ 102, 109, 113, 118, 123, 130, 133, 141, 156, 175, 31, 33, 36, 37, 43, 45, 46, 
47, 51, 55, 62, 63, 64, 65, 66, 67, 69, 73, 74, 76, 81, 83, 84, 85, 88, 89, 91, 
92, 93, 94. 
O2+ 101, 103, 109, 111, 113, 117, 118, 122, 124, 135, 137, 139, 141, 142, 147, 
153, 169, 185, 191, 18, 19, 28, 30, 31, 33, 36, 37, 41, 43, 45, 46, 47, 48, 49, 
51, 52, 54, 55, 60, 63, 64, 65, 66, 67, 68, 69, 70, 73, 74, 75, 76, 77, 78, 83, 
84, 85, 89, 91, 92, 93, 94, 95, 96. 
Table 6.2: List of Significant M/Z ratios (P value <0.05) expressed by the Gastric cells 
cultured as monolayer. 
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6.3.2. Volatile signatures of gastric cancer cells in Spheroid (3D) culture: 
Table 6.3 showed the list of significant M/Z ratios (p.value < 0.05) representing the VOCs 
released by the spheroids on alternate days till day 12. For HS 738 (normal gastric) spheroids 
produce 8, 5 and 4 significant M/Z ratios on day 2, 4, and 6 respectively. Nine significant 
M/Z ratios were observed after the treating with 75 mg curcumin on the day 8, whereas 19 
and 36 significant M/Z ratios were found after treated with 150 mg curcumin on day 10 and 
day 12 day respectively. These results clearly showed that these spheroids produce volatiles 
in response to the curcumin treatment (Table 6.3). Among these M/Z ratios, 3 were consistent 
during the entire course of the curcumin treatment (H3O+ - 99; NO+ - 98; O2+ - 98) and 11 
M/Z ratios were consistently observed after 150mg curcumin treatment (H3O+ - 100, 129, 
135, 137, 192; NO+ -104, 128, 134, 136, 138, 154, 158; O+ - 128). From figure 6.2, it was 
evident that the morphology of HS 738 spheroid was unaltered, which suggested that these 
volatiles were produced as a result of the cytoprotective mechanism against the curcumin or 
the byproducts of curcumin catabolism. These results showed that there was an interaction 









Age of the Spheroids 
2 Days 4 Days 6 Days 8 Days 10 Days 12 Days 
Curcumin concentration 
NIL NIL NIL 75 mg 150 mg 150 mg 






























O2+ 102, 120, 175, 
82. 
121, 82. 160. 140, 98, 
99. 
128, 98. 144, 128, 
155, 98, 
99. 
MKN 28 H3O+ 154, 163, 178, 
186, 198, 200, 
21, 35, 42, 45, 

















NO+ 116, 141, 180, 
43, 44, 74. 









74, 79.  
O2+ 154, 157, 180, 






43, 74. 151, 43, 
61, 98. 
110, 81. 119, 136, 
43, 81, 
93. 
IST 1 H3O+ 101, 103, 104, 
117, 121, 122, 
125, 129, 137, 
139, 141, 175, 
191, 29, 43, 45, 
46, 51, 52, 57, 
58, 63, 64, 71, 
















NO+ 102, 103, 104, 
127, 150, 156, 
170, 43, 44, 57, 
58, 61, 70, 73, 
74, 79, 86, 87, 

















136, 38. 134, 136, 
139, 57, 
84. 
O2+ 103, 115, 121, 
127, 133, 36, 43, 
44, 45, 57, 59, 
60, 61, 63, 64, 
73, 75, 77, 79, 





















SNU 484 H3O+  197. 162. 118, 137, 
154, 99. 
182. 43, 47, 
61, 64, 
79. 









98. 60, 63, 
65, 76, 
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NUGC 3 H3O+ 103, 115, 149, 
185, 45, 46, 57, 
63, 64, 78, 89, 
































NO+ 158, 185, 43, 44, 




























O2+ 120, 41, 43, 59, 
61, 70, 79. 













Table 6.3: List of Significant M/Z ratios (P value <0.05) expressed by the Gastric spheroids 
under the untreated condition and after subsequent treatment with curcumin. 
 
MKN 28 spheroids produce 29, 16 and 8 significant M/Z ratios on day 2, 4, and 6 
respectively. In response to the curcumin treatment, the number of significant M/Z ratios 
increased to 19 on day 8 (75 mg), 10 on day 10 and 15 on the day 12 (Table 6.2). Three 
significant M/Z ratios were produced during the entire curcumin treatment (H3O+ - 45, 63; 
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NO+ - 43) and three M/Z ratios (H3O+ - 135; NO+ - 135; O+- 81) were observed specifically 
after 150mg curcumin treatment (day 10 and 12). IST 1 spheroids produce 73, 36 and 20 
significant M/Z ratios on day 2, 4 and 6 respectively. After the 75 mg curcumin treatment, 
these spheroids release VOCs represented by 25 significant M/Z ratios, which reduced to 6 
after 150mg curcumin treatment on day 10 and then increased to 14 on day 12 (Table 6.2). 
Seven significant M/Z ratios were produced consistently before curcumin treatment (H3O+ - 
71; NO+ - 73. 74, 86; O+ - 36, 87, 89). The M/Z ratios NO+ -136+ and O2+- 70+ were produced 
consistently during the 150mg curcumin treatment.  
Figure 6.2 showed that the MKN 28 was completely unaffected and IST 1 spheroids were 
moderately affected due to the curcumin treatment, which suggested that both these cell lines 
survived by evading curcumin-induced cell death or apoptosis. Thus these significant M/Z 
ratios were representative of curcumin-induced cell death evasion. It was also important to 
note that both MKN 28 and IST 1 followed different mechanisms for evading curcumin-
induced cell death, which is evident from the significant M/Z ratios. This differences might 
be due to the differences in the interaction of the curcumin with these spheroids, as the 
curcumin were capable of interfering vast array of metabolic pathways. 
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Figure 6.2: Micrographs Depicting the Effect of curcumin treatment on Normal Gastric 
spheroids and Gastric cancer spheroids (scale = 1 µm). 
 
NUGC 3 spheroids produced 30, 13 and 7 significant M/Z ratios on day 2, 4 and 6 
respectively. 26 M/Z ratios were observed after 75mg curcumin treatment, whereas 33 and 60 
significant M/Z ratios were found after 150mg curcumin treatment on day 10 and day 12 
respectively (Table 6.2). M/Z ratios H3O+ - 124, 127, 234, 135, 173, 22; NO+ -118, 87; and 
O2+- 118, 135, 89 were produced consistently during the 150mg curcumin treatment. Three 
significant M/Z ratios were produced till day 8 i.e., till 75mg curcumin treatment (H3O+ - 45, 
63; NO+ - 74). This suggested that these spheroids had certain degree of resistance to 75mg 
curcumin treatment. SNU 484 spheroids produced 1, 2 and 9 significant M/Z ratios on day 2, 
4 and 6 respectively.  In response to the 75mg curcumin treatment, SNU 484 spheroids 
produced 17 significant M/Z ratios whereas, treating with 150 mg of curcumin resulted in the 
production of 10 and 29 significant M/Z ratios on day 10 and day 12 respectively (Table 6.2). 
From the microscopic observation, it was evident that the curcumin treatment on both NUGC 
3 and SNU 484 spheroids resulted in the apoptosis. It was also clear that the in both 
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spheroids, the apoptosis was complete between day 10 and day 12. Hence the significant M/Z 
ratios produced on the day 12 represented the volatiles that were produced as a result of 
curcumin-induced cell death, and these M/Z ratios could be the potential biomarkers for 
curcumin-induced cell death/ apoptosis. On the other hand, the significant M/Z ratios 
observed on day 8 and 10 are the representation of these spheroids' initial response to 75mg 
and 150mg curcumin treatment respectively.  
6.4. Discussion: 
6.4.1. VOC signatures can classify normal gastric cells, primary gastric cancer cells and 
metastatic gastric cancer cells that are cultured as monolayer as well as spheroids: 
In monolayer culture, the normal gastric cells (HS738) released methylamine (O2+ - 31), 
which was specific to the normal gastric cells among the cells studied here. As for gastric 
cancer cells, both the primary and metastatic gastric cancer cells released seven VOCs, which 
were not observed in normal gastric cells. Thus these seven VOCs could be considered as the 
biomarkers of gastric cancer. These seven VOCs were formaldehyde (H3O+ - 31; O2+ - 31, 
60), methanol (H3O+ - 33, 51, 69; NO+ - 62; O2+ - 31), cyanoacetylene (H3O+ - 52), 
cyclohexane (H3O+ - 83, 85), phenylamine (H3O+ - 94; NO+ - 93; O2+ -93), 2-hexane (H3O+ - 
85; NO+ - 83, 84) and Methane (O2+ -47). Interestingly, the release of methylamine by the 
normal gastric cells and phenylamine by the gastric cancer cells suggested that there existed 
an alteration in the alkyl amine biosynthesis between the normal and cancerous gastric cells. 
Metastatic gastric cancer cells specifically released nitrous acid, nitric acid, and 2,3-
butadiene. Thus these three VOCs could be considered as biomarkers of metastatic gastric 
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Table 6.4: List of identified VOCs released by the Gastric cells cultured as monolayer. 
 
On the other hand, in the spheroid culture, under the untreated condition, the normal gastric 
spheroids specifically released acetone (H3O+ - 59; NO+ - 88), which was consistently 
released from day 2 to day 6. Hence, it was certain that acetone could be the biomarker for 
the normal gastric spheroids. It was previously reported that acetone was expressed by 
primary human bronchial epithelial cells [171]. We could not be able to identify common 
VOC biomarker for primary and metastatic gastric cancer spheroids as the primary gastric 
spheroids did not release any detectable VOCs. However, we identified acetaldehyde (H3O+ - 
45; NO+ - 43, 74; O2+ - 43) as the VOC biomarker for the metastatic gastric cancer spheroids. 
Acetaldehyde was observed consistently till day 6 (untreated condition) in all the metastatic 
spheroids (Table 6.5). Acetaldehyde has been already reported as a lung cancer biomarker in 













Age of the Spheroids 
2 Days 4 Days 6 Days 8 Days 10 Days 12 Days 
Curcumin concentration 
NIL NIL NIL 75 mg 150 mg 150 mg 






































































Table 6.5: List of identified VOCs released by the Gastric spheroids under the untreated 
condition and after subsequent treatment with curcumin.  
        
6.4.2. VOCs signature of cells cultured as monolayer and as spheroids were dissimilar: 
As the number of cells in the monolayer culture and spheroid culture were different, the 
volatile signatures obtained from monolayer culture and spheroid culture were not 
comparable in the quantitative aspect. However, comparing qualitatively, it was evident that 
the VOC signatures of all the studied gastric cells in monolayer culture were different from 
that of the same cells cultured as spheroids. Numerous previous studies showed the similarity 
of spheroid culture with the in vivo cells, as all the characteristics of the in vivo cells like 
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nutrient and waste gradients, cell proliferation gradients, heterogeneity, etc. were preserved in 
the cells cultured as spheroids [88-91, 146-147]. Thus the VOC biomarkers that were 
identified in the spheroids were suitable for the clinical translation and further basic biology 
investigation. These results were yet another proof of the differential behavior of cells in 2D 
culture and 3D cultures. 
6.4.3. Effect of Curcumin Treatment on Normal Gastric Spheroids and Gastric Cancer 
Spheroids: 
It is evident from the figure 6.2 that the HS738 and MKN 28 remain intact after the complete 
curcumin treatment whereas, curcumin treatment in IST 1 spheroids of results in the 
fragmentation of the tumor spheroids. On the other hand, in the case of SNU 484 and NUGC 
3 spheroids curcumin treatment resulted in apoptosis. These results suggested that curcumin 
treatment was more effective for poorly differentiated gastric cancers than moderately 
differentiated gastric cancers and does not affect the normal gastric cells (Table 6.1). 
6.4.4. Curcumin treatment alters the volatile signatures of the gastric spheroids: 
The volatile signatures of all the gastric spheroids were modified by the curcumin treatment. 
Among the 5 gastric spheroids studied, two spheroids (HS 738 and MKN 28) evaded the 
cytotoxicity of the curcumin, whereas IST 1 was moderately affected resulting in the 
fragmentation of the spheroids but did not undergo cell death. However, the other two 
spheroids, namely SNU 484 and NUGC 3 have been affected by the curcumin treatment 
resulting in apoptosis of these spheroids. Hence, the VOCs observed in the HS 738, MKN 28 
and IST 1 after curcumin treatment were the curcumin-induced cell death evasion associated 
volatiles whereas, the VOCs found in SNU 484 and NUGC 3 after the curcumin treatment 
were the curcumin-induced cell death associated volatiles. 
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Normal gastric spheroids (HS 738), did not release its signature volatile acetone after the 
curcumin treatment, instead released pentyl furan (H3O+ - 139; NO+ - 138) and 3-methyl 
thiophene (H3O+ - 99; NO+ - 98; O2+ -98) after treating with 75mg curcumin. With the 150mg 
curcumin treatment, they release additional volatiles one being furaneol. It is noteworthy that, 
curcumin treatment ceased the release of acetone and induced release of pentyl furan (H3O+ - 
139; NO+ - 138), 3-methyl thiophene (H3O+ - 99; NO+ - 98; O2+ -98) and furaneol (H3O+ - 
129; NO+ - 128, 158; O2+ -128). This observation provided an insight that curcumin interacted 
with the metabolic pathway which synthesized acetone and it is evident that these three 
volatiles produced after curcumin treatment represents either by product of curcumin 
metabolism or volatiles associated with the cytoprotection mechanisms or both. 
 
Interestingly, MKN 28 spheroids could retain its volatile signature namely acetaldehyde even 
after the complete curcumin treatment, but they released certain additional VOCs, in response 
to the curcumin treatment. The consistent acetaldehyde expression is coinciding with the 
unaltered morphology of the MKN 28 after the curcumin treatment suggesting that MKN 28 
spheroids had a mechanism to prevent itself from curcumin treatment without compromising 
its normal metabolism. When treated with 75mg curcumin, MKN 28 spheroids responded 
with the production of furfuryl alcohol (H3O+ - 81; NO+ - 98; O2+ -98). When the curcumin 
dosage was increased to 150mg, they released carveol (H3O+ - 135; NO+ - 135). Carveol is a 
hydroxylated monoterpene, which was shown as a chemopreventive agent against mammary 
gland carcinogenesis [182]. IST 1 retains its acetaldehyde (H3O+ - 45; NO+ - 43, 74; O2+ - 43) 
release even after treating with 75 mg curcumin but it ceased to release acetaldehyde after the 
150mg curcumin treatment. However, after the 75mg treatment they released carbonyl sulfide 
(O2+ - 60) in addition of acetaldehyde but after the 150mg treatment they produce different 
volatiles like 4-isopropyl toluene (H3O+ - 135; NO+ - 134; O2+ - 119). This finding suggested 
	 111	
that IST 1 spheroids were responding to curcumin treatment in a dose-dependent manner. 
Even though the curcumin treatment caused fragmentation of the IST 1 spheroids, the cells 
did not undergo apoptosis even after another dose to 150mg curcumin (data not shown). This 
observation revealed that volatiles like 4- isopropyl toluene could be the manifestation of cell 
death prevention mechanism but not the fragmentation of the spheroids. 
 
SNU 484 spheroids were one of the two cell lines that underwent apoptosis. This primary 
gastric cancer spheroids, released 3- methyl thiophene (H3O+ - 99; NO+ - 98; O2+ -98) and 
furaneol (NO+ - 128, 158) when treated with 75mg of curcumin and 150mg of curcumin. 
From figure 6.2, it is evident that SNU 484 spheroids underwent apoptosis after the first dose 
of 150mg curcumin. Formic acid (H3O+ - 43, 61; NO+ - 59; O2+ - 45)/ nitrogen dioxide (O2+ -
46), nitric acid (H3O+ - 64), methane (O2+ -47) and ethyl chloride (O2+ -63, 65) that were 
observed after the second dose could be the manifestation of apoptosis. Thus, these VOCs 
were the curcumin-induced cell death associated volatiles. Another cell line that underwent 
apoptosis in response to curcumin treatment was NUGC 3. These spheroids were resistant to 
the 75mg curcumin treatment, which was evident from the release of acetaldehyde even after 
75mg of curcumin treatment. But once treated with the first dose of 150mg of curcumin, 
these spheroids ceased their acetaldehyde production and released other higher aldehydes, 
pentanal (H3O+ - 69, 87; NO+ - 85; O2+ -44, 58) and benzaldehyde (H3O+ - 107; NO+ - 105). 
On the second dose of 150mg curcumin the cells in the NUGC 3 spheroids underwent 
complete apoptosis and released acetonitrile (H3O+ - 42, 96), 1-nitropropane (H3O+ - 90; NO+ 
- 119)/ urethane (H3O+ - 90; NO+ - 119; O2+ -89), benzoic acid (H3O+ - 123; NO+ - 152; O2+ -
122)/2-methyl-3-ethyl pyrazine (H3O+ - 123; NO+ - 152; O2+ -122). These volatiles could also 
be regarded as the curcumin-induced cell death associated volatiles. It is noteworthy to 
mention that SNU 484 and NUGC 3 might have undergone apoptosis by following different 
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mechanisms, which was evident from their initial to response to curcumin treatment and also 
by the volatiles observed after complete apoptosis (Table 6.4). 
6.4.5. Sensitivity to curcumin treatment varies between different gastric cells cultured 
as spheroids: 
This study showed that the cell lines differ in their sensitivity to curcumin treatment. The 
gastric cancer spheroids of cell lines MKN 28 was completely immune to curcumin treatment 
whereas, IST 1 and NUGC 3 shows resistance to lower doses of curcumin, which was evident 
from the release of acetaldehyde. However, HS 738 and SNU 484 were highly sensitive to 
the curcumin even at the lower doses. It is imperative to note that, two out of five cell lines 
(HS 738 and SNU 484) studied, produces 3- methyl thiophene and furaneol as their response 
to curcumin treatment. Interestingly among these two cell lines SNU 484 underwent 
apoptosis whereas, HS 738 survived the curcumin treatment. This observation suggested that 
3- methyl thiophene and furaneol did not play any role in either apoptosis or evasion of 
apoptosis. We could observe an additional VOC called pentyl furan released in HS 738 that is 
not released by SNU 484, which showed that pentyl furan could be released as a result of 
apoptosis evasion mechanism by HS 738. 
Another interesting observation was these metastatic gastric cancer spheroids were able to 
retain the production of acetaldehyde even after 75mg curcumin treatment along with some 
new M/Z ratios and when treated with 150mg curcumin treatment they stop producing their 
volatile biomarker namely acetaldehyde (with the exception of MKN 28) and produced 
volatiles in response curcumin treatment. These significant M/Z ratios that were produced 
before and after 150mg curcumin treatment were completely different. This data suggested 





This study used multicellular spheroids to reproduce the in vivo cellular microenvironment in 
vitro as close as possible. Acetaldehyde was found to be a potential volatile biomarker for 
diagnosing metastatic gastric cancer. All the normal gastric spheroids and gastric cancer 
spheroids studied produced specific volatiles in response to the curcumin treatment. Each and 
every cell line studied gave their unique response to the curcumin treatment by expressing 
unique volatile signatures. Observations on acetaldehyde expression by the metastatic gastric 
cancer spheroids after curcumin treatment suggest that these cells respond to curcumin in a 
dose-dependent manner. These volatile signatures would be useful in monitoring the progress 
of the curcumin treatment against cancer. This study was first of its kind, and still, there is a 
lot of research that needs to be done to relate the volatiles represented by the significant M/Z 
ratios with the established metabolic pathways, which would be indispensable in 
understanding the disease metabolism and developing better ways of diagnosis and treatment.   
 
6.6. Summary: 
Gastric cancer has the third highest mortality rate among all other cancers due to the lack of 
non-invasive and early detection methods. Various studies showed volatile signatures of the 
cancer cells could be used as biomarkers for cancer detection, where in the case of gastric 
cancer, curcumin was identified as a potential drug candidate for treatment. In this study, we 
investigated four gastric cancer cells lines (SNU 484, IST 1, MKN 28, NUGC 3) and one 
normal gastric cell line (HS 738), for the identification of gastric cancer-specific volatile 
biomarkers, where we intend to decipher the curcumin-induced volatile signatures of the 
gastric cancer spheroids. Among the five cell lines, three cell lines (MKN 28, IST 1 and HS 
738) were wholly or partially resistant to curcumin treatment whereas the other two cell lines 
(SNU 484 and NUGC 3) were susceptible to the curcumin treatment which led to the cell 
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death. Our results suggests that the curcumin treatment triggers either the production of 
curcumin-induced cell death associated volatiles (as seen in SNU 484 and NUGC 3) or 
curcumin-induced cell death evasion associated volatiles (as seen in MKN 28, IST 1 and HS 
738), which could be considered as potential biomarkers for accessing the outcome of 
curcumin treatment. This study opens up further research to decipher the role of these 
volatiles in curcumin associated cell death and curcumin associated cell death evasion. Any 
biomedical study is not considered complete without clinical translation of the experimental 
results. The aim of volatile signature identification experiments using 3D spheroid method is 
to prove the existence of gastric cancer associated volatile signatures. This in vitro 
confirmation is very important before pursuing a clinical study.	Furthermore, a specialized 
breath collection instrument was developed to collect end-tidal breath from human subjects. 
Our next study is to collect and identify the VOCs in the exhaled breath samples of gastric 
cancer subjects and non-gastric cancer subjects. Our aim of this study is to compare the 





















Identification of Non-Invasive Breath Biomarkers for the 
Diagnosis of Gastric Cancer- A Clinical Study 
 
7.1. Background: 
According to World Health Organization, gastric cancer (0.72 million deaths) ranks third in 
cancer mortality worldwide in 2012, with the highest incidence in the Asia-Pacific region [1]. 
Given high global incidence rate, early diagnosis of gastric cancer appears to improve 
survival rates [183]. The gold standard for the diagnosis of gastric cancer is 
esophagogastroduodenoscopy (EGD) and biopsy. When a doctor identifies an abnormal 
tissue area through EGD, he/she will perform a biopsy of the suspected tissue followed by the 
microscopic examination. However, this is expensive and invasive; hence it is not a cost-
effective screening tool for most countries.  
   
 




Previous studies in this thesis have shown that cells release VOCs in response to its 
physiological and pathological conditions. The volatiles released by the cells are dissolved in 
the blood. These VOCs were carried to the alveoli via blood flow and excreted out during 
exhalation [184]. Many prior studies have identified several breath based biomarkers for 
various diseases including cancer.   In breath research for cancer diagnosis, studies on lung 
cancer dominate due to lung's association in gaseous exchange and exhalation. Gordon et al. 
(1985) compared the breath VOCs of lung cancer subjects and healthy subjects and identified 
acetone, methyl ethyl ketone, and n-propanol as potential biomarkers of lung cancer [185]. 
Michael Phillips et al. (2003) developed a diagnostic, predictive model based on the VOCs 
identified in exhaled breath and identified primary lung cancer with a sensitivity of 89.6% 
and specificity of 82.9% Whereas, metastatic lung cancer was detected with a sensitivity of 
66.7% [186].  
In an another study Chen et al. reported styrene, decane, isoprene, benzene, undecane 1-
hexene, hexanol, propyl benzene, 1,2,4-trimethyl benzene, heptanal, and methyl cyclopentane 
as breath markers of lung cancer [187]. Ligor et al. (2009) identified 8 VOCs 1-propanol, 2-
butanone, 3-butyn-2-ol, benzaldehyde, 2-methyl-pentane, 3-methyl pentane, n-pentane and n-
hexane as potential breath biomarkers of lung cancer [27]. Bajtarevic et al. (2009) identified a 
set of 21 VOCs as the breath markers of lung cancer [188].  Fuchs et al. (2010) identified 
pentanal, hexanal, octanal and nonanal as the breath biomarkers for lung cancer [181]. Wang 
et al. (2014) had identified caprolactam and propionic acid as the lung cancer biomarkers 
[189]. Filipiak et al. (2014) compared the VOCs released by the lung cancer transformed cell 
lines, lung cancer tumors and exhaled breath of lung cancer patients. They identified ethanol 
and octane as the lung cancer biomarkers as these two VOCs are observed in all the three 
types of lung cancer samples [190].  
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Few studies investigate the breath biomarkers of cancers in the alimentary canal. Kumar et al. 
(2013) discovered 4 VOCs hexanoic acid, phenol, methyl phenol and ethyl phenol as the 
breath markers for oesophagogastric cancer [191]. In the latest study by the same group, 12 
breath VOCs pentanoic acid, hexanoic acid, phenol, methyl phenol, ethyl phenol, butanal, 
pentanal, hexanal, heptanal, octanal, nonanal, and decanal were identified as the potential 
biomarkers of esophageal and gastric adenocarcinoma [192].  
It is evident from the studies focused on the identification of the breath based lung cancer 
biomarkers that those studies are incomparable mainly due to the complexity of the disease, 
sampling methodology, subject recruitment criteria and demographic differences [193]. This 
finding could be true for gastric cancer also. Thus identification of the breath biomarkers for 
gastric cancer in Singapore population becomes imperative. Breath biomarkers for gastric 
cancer in Singapore population can be identified by comparing the volatile organic 
compounds (VOCs) in the exhaled breath obtained from gastric cancer patients and non-
gastric cancer subjects, using Gas chromatography and mass Spectrometry (GC-MS). Given 
that the 13C urea breath test has become a popular non-invasive rapid diagnostic procedure 
for detecting H. pylori infection in the human stomach in the clinic [194]. Our objective is to 
develop a non-invasive method for gastric cancer detection through the volatile organic 
compounds (VOCs) biomarkers in the exhaled breath.  
7.2. Methods and Materials:   
7.2.1. DSRB approval and Subject recruitment:  
This clinical study has been approved by the Domain specific review board (DSRB) 
Singapore. The DSRB approval letter has been included as appendix 3. A total of 22 exhaled 
breath samples (gastric cancer = 11 and Non-gastric cancer = 11) were collected and 
analyzed in this study. All the subjects were recruited after screened by the current gold 
standard diagnostic procedure namely esophagogastroduodenoscopy (EGD) (Table 7.1). 
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Subject Parameter  Gastric cancer Cohort Non-gastric cancer cohort 
Mean age (S.D) in years 62.2 (15.2) 62.3 (9.9) 
Median age in years 67 64 
Male 9 8 
Female 2 3 
Race: Chinese 9 10 
Race: Others 2 1 
Total number of subjects 11 11 
Table 7.1: Details of the subjects participated in the study.  
7.2.2. A sampling of exhaled breath: 
The main criteria for the selection of gastric cancer and non-gastric cancer subjects were the 
presence and absence of gastric cancer tumor respectively, confirmed by the gold standard 
diagnostic method. All the other intragroup variations were allowed. These intra-group 
variations were intentionally allowed after considering the real clinical scenario. The main 
aim of this study is to differentiate between the gastric cancer subjects from non-gastric 
cancer subjects irrespective of the stage of gastric cancer. The two groups were age and 
gender matched. The subjects were in fasting and restricted from diet, smoking and alcohol 
consumption for 8 hours before esophagogastroduodenoscopy in order to minimize the 
background noises. The non-gastric cancer subjects were the people underwent the 
esophagogastroduodenoscopy because of their gastro intestinal problems other than cancer, 
which was also done intentionally in due consideration of the real clinical scenario where 
who come for the gastric cancer diagnosis will have either have gastric cancer of some other 
gastro intestinal problem. The breath samples were collected by trained paramedics. A demo 
video detailing the breath collection procedure is shown to the subjects before breath 
collection. For the breath sampling, the subjects need to undergo a simple procedure, which 
involves 3 minutes of lung flushing and followed by breath sampling. The lung flushing 
involves the deep inhalation (where the depth of inhalation is depends on the comfortability 
of the subjects) followed by exhalation for 3 minutes. The three minutes breathing was 
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performed to increase the volumetric lung capacity to maximize the gaseous exchange. 
Breath sampling involves the collection of end tidal breath in the custom-made glass end tidal 
breath collection device. The glass end tidal breath collection device was designed for 
capturing the last 55-60mL of the exhaled breath. Another glass collection device was used to 
trap the ambient air, which will act as the environmental control. An average human exhales 
approximately 500mL of air during each exhalation. In that 500mL only the last 350mL air is 
the result of gaseous exchange in lungs, which contains the crucial chemical information for 
the disease diagnosis [195]. The cancer patients will be either weak or aged so that they 
exhale a lesser volume of air when compared to the healthy volunteers. We took this into 
consideration and made the sampling volume to 55-60mL. 
 
 
Figure 7.2 Custom-made silanized end-tidal breath collection tube. 
 
The prime motivation for designing the custom-made silanized end-tidal breath collection 
tube was that the commercially available breath bags were found to be not suitable for our 
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study. These breath bags collect the entire breath which leads to the dilution of the end-tidal 
gas and increases background noise. In our previous study where we used the breath bags for 
breath, the collection gives only the background noise. So we designed our end tidal breath 
collection device (figure 7.2). Our device has 5 components namely one-way valve, high 
vacuum inlet stopper, glass bulb, sampling port and high vacuum outlet stopper. The design 
of the glass bulb is crucial. The slope between the inlet tube and the glass bulb should be 
minimum to reduce the air recirculation phenomenon. Another important factor is the 
silanization of the glass bulb. Silanisation will deactivate the highly reactive silanol groups 
on the glass surface. If silanization is not performed, these silanol groups will react with the 
polar gas compounds thus affecting the outcome of the experiment. When the subject blow 
air through the one-way valve the air travels through the glass bulb and exit through the 
outlet stopper. The subject is instructed to close the outlet stopper first when they are about to 
complete their exhalation, followed by the closure of the inlet stopper, thus trapping the last 
55-60 mL of the end tidal breath. The trapped breath can be sampled from the sampling port, 
which is lined with gas tight replaceable Teflon septa. 
 
7.2.3. Solid Phase Micro-Extraction (SPME) sampling: 
Solid-phase microextraction of the VOCs was performed using the CUSTODION® SPME 
Syringe, StableFlex needle, 23 GA with DVB/PDMS fiber (Torion Technologies Inc. USA). 
The DVB/PDMS fiber was carefully placed in the atmosphere of the end-tidal breath 
collection flask through the sampling port for 45 minutes at room temperature. After 
incubation, the fiber was carefully retracted into the syringe and taken out from the culture 
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atmosphere. The VOC metabolites were then identified using gas chromatography and mass 
spectrometry (GCMS) (Figure 7.3). 
 
Figure 7.3: Experimental procedure of the clinical study. 
7.2.4. Gas chromatography and mass spectrometry (GCMS): 
The VOC metabolites were identified using gas chromatography and mass spectrometry 
(Shimadzu GCMS-QP2010 Plus system, Japan, with a 0.25 mm x 30 m DB-5MS column that 
had a 0.25um phase film thickness). The SPME syringe needle was inserted into the GCMS 
injection port and the fiber was extended for 10 minutes to allow for desorption of the VOC 
metabolites. Helium carrier gas was maintained at a flow rate of 1.0 mL/min. The initial GC 
oven temperature of 40°C was held for 5 minutes, followed by a temperature ramp of 5°C per 
minute up to 200°C followed by the second ramp of 10°C per minute up to 270°C. The mass 
spectrometer transfer line was maintained at 280°C, and the source temperature is 230°C. 
Mass spectra were repeatedly scanned from 20-700 m/z. The acquired mass spectrum was 
matched with the mass spectrums of the National Institute of Standards and Technology 
(NIST) MS spectral library and the mass spectrums NIST 08 mass spectral database, National 
Institute of Standards and Technology, Washington, DC, USA. The following quasi-linear 
equation for temperature-programmed retention indices was used to confirm the compound 
identification.  
RIx = [(tx − tn)/(tn+1 − tn)]100 +100n 
where RIx is the temperature-programmed retention index of interest and tn, tn+1, tx the 
retention time in minutes of the 2 standard n-alkanes containing n and n + 1 carbons and 
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index of interest, respectively [155].  
7.2.5. SIFT-MS analysis for accessing the working of end-tidal breath collection tubes: 
To access the suitability of the custom made end-tidal breath collection device, the collected 
breath samples were fed into the SIFT-MS (Voice 2000, New Zealand) at the rate of 25 
standard cubic centimeters (sccm) using an 18-gauge needle. A full mass scan (M/Z range: 18 
– 200) was performed with three reaction ions namely H3O+, NO+ and O2+. The M/Z ratios 
and their corresponding counts were collected. For the convenience of data comparison, all 
the samples were analyzed on the same day one after the other. All the statistical analysis was 
performed by the MetaboAnalyst 3.0, online statistical software (www.Metaboanalyst.ca/, 
Canada) [54]. The collected M/Z ratios with their counts were converted into single 
concatenated vector in order make it compatible for the MetaboAnalyst 3.0. The product ion 
count rate depends on the precursor ion count rate which varies from day to day; we 
conducted a normalization procedure in which product count rates of each sample were 
divided by corresponding H3O+, NO+, and O2+ precursor count rates [168]. Statistical 
methods, such as heat map analysis of the significant product ion M/Z ratios, clustering 
analysis, t-test, etc., were performed using MetaboAnalyst 3.0 after logarithmic normalization 
and auto scaling. 
7.3. Results and Discussions: 
7.3.1. The efficiency of breath collection tube: 
The assessment of the effectiveness of breath collection tube in separating the end tidal 
breath from the total tidal volume is critical. To study this, we have compared the SIFT-MS 
breath profiles of the ambient air and the breath collected at the same place. The breath tubes 
are apt for the breath studies, if and only the difference between these samples mentioned 
above were strikingly different. Figure 7.4 shows eight heat map depicting the significant 
variation in the volatile profiles between eight breath samples (VB series) and their 
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corresponding ambient samples (Control). From the heat maps, it is clear that the variation of 
the breath profiles is radically different from its ambient samples. Thus, we conclude that 
these breath collection tubes were suitable for the	end	tidal	breath	collection.			
7.3.2. Breath biomarkers of gastric cancer: 
GC-MS analysis of the breath samples results in the identification of 69 VOCs. Among the 
69 VOCs, 19 were observed only in the gastric cancer cohort and 35 VOCs were found 
exclusively in the non-cancer group. However, 15 VOCs were noted in both cancer and non-
cancer group (Figure 7.5). Among these 19 breath markers associated with the gastric cancer 
group only 9 markers were identified by retention index identity.  In a complex disease like 
cancer, where each and every tumor is unique, it is highly impossible to determine a single or 
few compounds that could identify all the gastric tumors. Hence, the aim of this study is to 
define a panel of VOCs that are observed only in the gastric cancer cohort. In this 
perspective,	 the 19 VOCs (Table 7.4) found in gastric cancer were considered as gastric 
cancer specific breath biomarkers.    
7.3.3. Lipid peroxidation is the major origin for the gastric cancer breath markers: 
Silva et al. (2011) identified cymene as a volatile urinary biomarker for various cancers 
including colorectal cancer, leukemia, and lymphoma. Bajtarevic et al. (2009) and Mochalski 
et al. (2014) described that cymene could be of exogenous origin and excluded this 
compound from their biomarker list [188, 196, 197]. Hence considering cymene as VOC 
biomarker of gastric cancer remains inconclusive. Sethi et al. (2013) observed tetradecanoic 
acid as one of the seven breath biomarkers for tuberculosis [167]. Perhaps, tetradecanoic acid 
and hexadecanoic acid or palmitic acid could be the product of lipid peroxidation induced by 
reactive oxygen species (ROS) [198]. Further, hexadecanoic acid was already reported as the 
biomarker for in-vitro cultured melanoma cells [199]. Alkanes and methylated alkanes were 
well known as the standard breath markers of lipid peroxidation in cancer cells [20, 21, 186 
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and 195]. Hence, compounds like isohexadecane, 2,6,10,15, tetramethyl heptadecane also 







Figure 7.4: Heat maps showing eight heat map depicting the significant variation in the 
volatile profiles between eight breath samples (VB series) and their corresponding ambient 
samples (Control). 
 




S. No Breath markers 
Gastric Cancer cohort Non-Gastric cancer cohort Observed in both 
cohorts 
1 2,6,10-trimethyl dodecane 1-iododecane Phenol 
2 1-iodoheptane 1-iodo nonane Indole 
3 2-heptyl thiophene Diisobutyl phthalate Menthol 
4 Tetradecanoic acid 2,3 pentanedione Anethol 
5 Palmitic acid 4-dodecanol Carvone 
6 Isohexadecane Menthone Limonene 
7 2,6,10,15, tetramethyl 
heptadecane 
Isomenthol 1,3-Dichlorobenzene 
8 Cymene Isopropyl phenol 1-Hydroxy-2,4,4-
trimethyl-3-pentanyl 
2-methylpropanoate 
9 1-Iodododecane Bornyl acetate Eucalyptol 
10 RT = 19.125 2,4-dimethylbenzaldehyde Anisole 
11 RT = 22.483 2-heptyl-1,3-dioxolane Farnesene 
12 RT = 22.967 7-Methoxy-3,7-
dimethyloctanal 
RT = 17.85 
13 RT = 23.183 1-iodononane RT = 23.358 
14 RT= 23.267 
 
3,5-Di-tert-butylphenol RT = 28.625 
15 RT = 26.442 1-iodoundecane RT = 32.117 
16 RT = 27.608 Menthofuran  
17 RT = 28.150 Neoisomenthol  
18 RT = 28.2 Caryophyllene  
19 RT = 28.675  Camphor  








24  Undecane, 2-methyl-2-
phenyl- 
 
25  11-heptadecenal  
26  1-Iodoheptane  
27  3-Methyltridecane  
28  2-Ethyl-3-hydroxyhexyl 2-
methylpropanoate 
 
29  RT = 13.508  
30  RT = 17.475  
31  RT = 17.983  
32  RT = 21.633  
33  RT = 21.908  
34  RT = 21.992  
35  RT = 26.692  
Table 7.2: List of identified breath biomarkers (RT- Retention time). 
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7.3.4. Probable origins of the breath VOCs observed in both cohorts: 
Phenol, Anethol, and menthol were two common ingredients of commercial mouthwashes 
[200, 201]. Thus, these two compounds were exogenic, arise from the mouthwashes used by 
the subjects. Carvone belongs to the terpenoid family of compounds usually, present in the 
caraway seeds and spearmint. Caraway oil (60% carvone) and spearmint oil (80% carvone) is 
a common ingredient in any commercial toothpastes and mouthwashes [202, 203]. 
Indole was observed as a result of oral malodor as this compound is closely associated with 
oral halitosis [204].  Limonene is commonly used in foodstuff and cleaning agents and 
halogenated compound like 1,3-dichlorobenzene should also potentially from exogenous 
origin [188]. 1,3-dichlorobenze had been identified in the breath of lung cancer patients, but 
it is not considered as a biomarker as the standard deviation is not within the acceptable range 
[205]. Eucalyptol (1,8-cineol) was observed potentially due to the administration of certain 
common medications as it is an active agent in the common non-prescription drugs used to 
remove airway blockages [206]. Anisole was also from exogenous sources, which traces its 
origin from medications or perfumes as anisole is a common precursor for pharmaceuticals 
and perfumes [207]. It is noteworthy that anisole is also claimed as urinary VOC biomarker 
for colon cancer [196]. Sophia et al. identified farnesene as one of the three breath 
biomarkers for invasive aspergillosis [208] but we consider farnesene could be exogenous 
from unidentified sources. The other unidentified compounds might also trace their origin 
either in the halitosis or from the products used for oral hygiene, diet and medications but yet 




7.3.5.  Critics of the prior studies focused on identifying breath biomarkers for gastric 
cancer:  
In the previous studies by Kumar et al. Phenol has been reported as gastric cancer breath 
marker, which contradicts our results. In the prior studies mentioned above, the authors 
suggested that the phenol was observed as a consequence of the increase in tyrosine 
breakdown by citing the studies of Deng et al. (2012) [191, 192]. Deng et al. showed that the 
elevated levels of aromatic amino acids like tyrosine and phenylalanine were associated with 
gastric cancer [209].  Unfortunately, there are no prior studies to show high levels of tyrosine 
breakdown in gastric cancer. Thus making the Kumar et al.’s proposal on explaining the 
phenol in breath invalid. In an another study, Amal et al. (2015) accessed the validity 8 VOCs 
as gastric cancer breath markers [210]. The authors concluded that 7 of these 8 VOCs were 
capable of detecting gastric cancer, but their data suggests that the standard deviation (SD) of 
the cancer cohort is too high and not acceptable if SD was taken into account. This 
discrepancy is attributed to the complexity of the disease making it tough identify VOCs that 
are unique to all the cases of gastric cancer. Thus, the better approach for detecting gastric 
cancer from exhaled breath is to define a panel of Breath markers that are only observed in 
the gastric cancer cohort. Gastric cancer could be diagnosed by looking at any one or more 
identified panel of breath markers in the subject's exhaled end-tidal breath.  
7.3.6. Differences in the volatile biomarkers of gastric cancer in vitro and in vivo: 
It is evident from the chapter 6 and chapter 7 that there is no correlation between the volatile 
biomarkers identified from the in vitro models and in vivo studies. This is expected because 
in the in vitro condition the volatile signatures of the specific cancer tumor model could be 
identified, whereas in the in vivo condition the volatile signatures we identify would be the 
collection of the volatiles released by the all the cells in the body due to their physiological 
and pathological status and the reaction products of these released volatiles. The idea behind 
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identifying cancer specific volatile biomarker in vivo is that cancer cells would produce 
unique volatile organic compounds (VOCs) as by product of cancer specific metabolism and 
get dissolved in the blood. These VOCs could react with the other VOCs that are produced by 
other cells and results in the reaction products that could be observed only in the presence 
cancer. These unique cancer-related VOCs can be observed in the exhaled breath as a result 
of alveolar gaseous exchange. 
 
7.4.	Conclusion: 
This study showed the successful employment of the custom made end-tidal breath collection 
tubes in the gastric cancer biomarker identification from exhaled breath. A panel of 17 
compounds associated with gastric cancer was identified, and their possible origin was 
discussed. Previous studies and their conflicts with the current study were addressed and 
explained. The effect of oral hygiene product usage was reflected in this study, which 
suggests that it is better to avoid the oral care products before breath collection. 
7.5.	Summary: 
This study portrays the discovery phase of the clinical study for the identification of gastric 
cancer biomarkers in exhaled breath. The custom made reusable end-tidal breath collection 
tube was successfully used in this gastric cancer biomarker identification studies. 17 VOCs 
that are associated with gastric cancer were identified, and among these 17 only 8 compounds 
names were identified. The majority of the identified compounds were associated with the 
lipid peroxidation of the cell membranes. 8 VOCs were observed in both gastric cancer and 
non-gastric cancer cohorts. All these 8 compounds trace their origin in either oral halitosis or 
oral care products. Hence, it is better to avoid the use of oral care products before breath 
collection to increase the signal to noise ratio. Though breath based non-invasive biomarkers 
for gastric cancer is identified, a low-cost, reliable, easy to operate, reusable and a compact 
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diagnostic tool is essential for mass screening procedures. Hence, the next step is to develop a 











































Florisensors: A novel flower-based chemiresistive volatile sensors 
 
8.1. Background: 
Olfaction in animals depended on their nose. Nose is a very delicate chemical sensor that can 
detect and discriminate between various gases [211]. Nose is an array of sensors with less 
specificity. Hence one sensing molecule can respond to many gases, and one gas can 
stimulate many sensing molecules present in the nose. These stimulations of the sensing 
molecules are interpreted by the olfactory cortex in the brain resulting in the odor detection 
[212-214].  There many continuous effects to replicate this olfaction using chemical sensors. 
Chemical sensor arrays were developed leading to the electronic nose that can simulate 
olfactory system of animals. In the electronic noses, the odors were detected from the pattern 
obtained from the responses of all the individual chemical sensors in the electronic nose 
[215]. The commonly used chemical sensors in e-nose were known as chemiresistors. The 
chemiresistive sensors change its resistances in response to their chemical environment. 
Chemiresistive sensors consist of a sensing material coated across the metal electrodes. When 
chemical vapors were exposed to these sensors, the vapors tend to percolate into the sensing 
materials and results in the swelling of the sensing material. This swelling alters the 
resistivity of the sensing material, thus increasing the resistance. The extent of percolation is 
depended on the partition coefficient of the gaseous vapor to the corresponding sensing 
material. This percolation phenomenon is reversible, thus making these sensors reusable 
[216].  
Conducting polymer composites, intrinsically conducting polymers and metal oxides are the 
commonly used sensing materials in the chemiresistive sensors. In the case of metal oxide 
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sensors, in particular, a heater is used as the high temperature is the prerequisite for the 
proper functioning of these sensors, thus making these sensors less energy efficient [217, 
218]. Conducting polymer composite based sensors are another class of chemiresistive 
sensors that uses conducting particles interspersed in insulating polymer matrices [219]. Most 
of the constituents of the conducting polymer composite based sensors were either expensive 
or hazardous. For instance, the most common conducting particle used is polypyrrole, which 
is prepared by the polymerization of pyrrole using phosphomolybdic acid in a solution of 
insulating polymer [220]. The resistance changes of polypyrrole sensors in response to the 
odor molecules were tough to predict as the chemical interaction of the odor molecules with 
the conducting polymer can also change in the intrinsic conductivity of the polypyrrole 
molecules. Another common type is the carbon black based composite sensor, which is 
hazardous as carbon black is a well-known carcinogen. 
Further nanomaterials such as functionalized gold nanoparticles, graphene and carbon 
nanotubes (CNTs) were also used as chemiresistors [221-226]. DNA functionalized graphene 
and nanomaterials were shown to exhibit chemiresistive properties in a sequence-dependent 
manner [226]. The drawbacks of these materials are that they are very expensive and requires 
hazardous chemicals and conditions for their preparation. Moreover, pristine graphene and 
CNTs were not sensitive enough for the chemiresistive applications. Hence additional step of 
creating defects in graphene and CNTs were required to enhance sensitivity [225]. 
Hence, a new sensing material, that is low-cost, easy to prepare and environmental friendly is 
highly needed. In this study, the possibility of using plant based extracts as the sensing 
material for developing chemiresistors was investigated. Reports from early 1980's showed 
that herbivore-induced volatiles released by the damaged leaves act as volatile cues for the 
undamaged leaves for enhancing their defenses against herbivore damage [227-229].   Plants, 
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when exposed to a green leaf volatile such as cis-3-hexenyl acetate and others results in the 
priming of the defense genes that mediate oxylipin signaling and direct defenses and defense 
metabolites like jasmonic acid and linolenic acid [230, 231].    Cuscuta pentagona, parasitic 
plant of Lycopersicon esculentum (Tomato) used the volatile cues for identifying the location 
of the host [232]. It is also demonstrated that the tobacco plant suffered lesser herbivore 
attack when grown near the clipped sagebrush than the tobacco plants grown near unclipped 
sagebrush [233 - 235]. An interesting study shows that lima beans produced more extrafloral 
nectar for attracting predators in response to the herbivore attack [236]. These studies clearly 
suggested that plants can perform olfaction, which means plants can detect and discriminate 
volatile compounds and respond to these volatile cues. Hence, we hypothesize that plant 
extracts can be utilized as chemiresistive sensing material in the volatile sensors. The 
objective of this study is to investigate the feasibility of using plant extracts as the volatile 
sensing material in the chemiresistive sensors. In this study, we show the capability of the 
plant extracts to function and sensing material in the chemiresistive sensors. As plant extracts 
are low-cost, non-hazardous, environmentally friendly and renewable, plant extracts have 
high potential in substituting energy inefficient, expensive and hazardous chemiresistive 
sensing materials.   
 
8.2. Methods and materials: 
8.2.1. Extraction of sensing material: 
Two plant species were selected for the fabrication of the florisensors namely Caesalpinia 
pulcherrima (C.pulcherrima) and Ixora coccinea (I.coccinea).  Sepals and petals from the 
Caesalpinia pulcherrima were separated and used to make two florisensors one with sepals 
and other with petals. Whereas, in Ixora coccinea, only the petals were used to make 
florisensors. Thus, in this study, we are investigating three florisensors. The flower materials 
	 134	
of these two plants were freshly collected and ground with a pestle as soon as possible. 
Ethanol was added as the extraction solvent in the concentration of 1µL/5mg of the grounded 
flower material, followed by further grinding of the flower material with ethanol. The extract 
was separated from the plant debris by ultracentrifugation at 10,000 rpm for 15 mins. The 
supernatants were saved forming the sensing material of the florisensors. 
 
8.2.2. Fabrication of the sensor:  
Commercially available wire glue is used as the base conductive layer. PET sheets are cut 
into required dimensions and terminals were created using copper strips and connecting pins. 
The flower based sensing material is embedded on the base conductive layer by drop casting 
method. In total 250 µL of the sensing, material was drop cast of the base layer. For the 
control sensor, 250µL of ethanol (extraction solvent) alone was drop cast on the base layer. 
Four sensors were mounted on the plastic lid a sensor array. The estimated cost of fabrication 
of the florisensor version described in the thesis would be 0.15-0.20 SGD per florisensor 
excluding work force cost. The cost of the florisensor array would depend on the number of 
florisensors used in the array(n). Hence, the total cost of florisensor array excluding 
workforce cost would be equal to n x (0.15) SGD to n x (0.20) SGD. 
8.2.3. Sensing milk to yogurt conversion: 
To test the chemiresistive functionality of the florisensors, we set up an experiment to check 
whether these sensors could detect the milk spoilage. 5 mL of cow's milk is taken from the 
1L milk pack bought from the local supermarket. A 100 µL of yogurt is added to the 10mL 
milk followed by closing it with a lid on which the sensor array was mounted. The resistance 
of the sensors at time zero was deduced and noted. Resistance readings were recorded for 
every 1 minute till the total duration of 12 hours using the voltage divider circuit connected to 
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the micro controller (Arduino Mega 2650). This entire experiment is repeated thrice, and the 
change in resistance is calculated from the obtained resistance readings (Eq. 1). 
 ∆R	 = -. − -)																																																		Eq.1 
 
8.2.4. Chemiresistive sensing of different flavors of smoothies: 
We set up another experiment, wherein the ability of the florisensor array to sense different 
flavors of smoothies were accessed. 5 mL of smoothie is taken in a glass beaker, and the 
beaker is closed with the lid on which the florisensor array is mounted. The resistance 
readings of the sensor array were recorded every 1 minute using the voltage divider circuit 
connected to the micro controller (Figure 8.1). This entire experiment was repeated thrice for 
each smoothie flavor, and the change in resistance is calculated from the obtained resistance 
readings (Eq. 1) 
 
 
Figure 8.1: A: Experimental setup and schematic representation of the florisensor. B: 
Florisensor array. 
 
8.3.  Results and discussion: 
8.3.1. Discriminating different flavors of smoothies: 
  The differential resistance (∆R) values from the recorded resistance values were calculated 
followed by deducing the mean differential resistance and standard deviation. Figure 8.2 
B	A	
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shows the ∆R responses of all the four sensors to the headspace volatiles of different flavors 
of smoothies. It is evident that the responses of the florisensors vary with the various flavors 
of smoothies and the control sensors did not show any significant variation, thus proving the 
chemiresistive properties of these florisensors. It is also observed that each flavor provoked 
distinct response pattern in the florisensor array, which suggests that, it is possible to 
discriminate different flavors of the smoothie based on the response pattern of the 
florisensors array. Radar chart was plotted using the ∆R values at which the sensor responses 
get saturated to visualize these distinct patterns, (Figure 8.3). It becomes evident that each 
and every flavor of the smoothie shows a distinct pattern in the radar chart. Thus the 
responses from these three florisensors were sufficient to discriminate all the 6 flavors of the 
smoothie tested. It is interesting to note that the strawberry flavor and mixed berry flavor 
shows very slight differences, which might be because of the phylogenetic closeness of 
berries. 
The variation in the resistances when exposed to the smoothies was attributed to the 
percolation of the volatiles into the sensing layer causing swelling and resulting in the 
resistance change. The specificity of these sensors was attributed to the partition coefficient 
of the volatiles in the sensing layer. If the exposed volatiles have high partition coefficient to 
the sensing layer, more volatiles percolate into the sensing layer causing more swelling 
resulting more change in resistance. Whereas, if the partition coefficient is low to the sensing 
layer, only few volatiles percolate causing less swelling leading to the minor change the 
resistance. Here, the partition coefficient depends on the plant extract which is used as the 
sensing layer. Hence, different plant extract responds differently to different volatiles thus 
creating distinct response patterns. The control sensor does not respond to the volatiles. 
Hence the partition coefficient of these volatiles in this sensor should be near zero. 
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Interestingly the sensor, in which C.pulcherrima sepal extract is used as the sensing layer 
does not vary drastically between different smoothies. This observation might be because 
partition coefficients of these volatiles were not radically different in this sensor, unlike the 
other two sensors. Hence, petal extract base florisensors were more informative than sepal 
extract based florisensors.     
Time taken by these sensor arrays to produce a stable saturated reading when exposed to an 
analyte is the limitation which was around 120 minutes. This limitation can be solved if we 






Figure 8.2: Chemiresistive responses of the florisensors and control when exposed to 






Figure 8.3: Radar plot showing the distinct pattern of the florisensor responses when 
exposed to different flavors of smoothies.  
 
8.3.2. Milk to yogurt conversion: 
Figure 8.4 shows the responses of the florisensor array in response to the conversion of milk 
to yogurt. From this plot, it was evident from the sensors drop-casted with C.pulcherrima 
petals and I.coccinea petals that milk to yogurt conversion completes in about 4 hours. The 
C.pulcherrima  sepals based florisensor does not saturate and tend to have a linear curve. 
This data shows that this sensor does not have specificity towards the volatiles produced due 
to yogurt formation. Thus, this sensor allows percolation of all the volatiles in the headspace 
resulting in the linear curve as the concentration of the headspace volatiles would increase 
with the yogurt formation. However, this sensor indicates the continuous changes undergone 
by the analyte (Milk) due to the yogurt inoculation. It is important to note that these sensors 
tend to recover spontaneously when the volatiles were removed. There were nanoparticle 
based sensors which need other external stimuli like UV exposure, thermal energy for the 
sensor recovery [237, 238]. This feature makes these sensors more energy efficient over those 
expensive and energy inefficient chemiresistive sensors.    
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Figure 8.4: Chemiresistive responses of the florisensors and control to the conversion of 
milk to yogurt. 
 
 
8.3.3. Specificity and sensitivity: 
The specificity of the florisensors in identifying different analyte has been demonstrated. As 
florisensor array can able to detect and distinguish between different flavors of yogurt 
smoothies with the florisensor finger prints. The specificity of this florisensor array could be 
further improved by adding more florisensors in the array, thus increasing the dimensionality 
of the florisensor fingerprints. The reproducibility of the florisensor array (n=3) along with 
standard deviation values at each data point has shown in figure 8.2 and figure 8.4.	This is a 
proof of concept demonstrating a novel way of volatile sensing by using the flower extracts. 
The future direction is to characterize these sensors, compare them with the existing volatile 
sensing platform regarding sensitivity and other sensor parameters and finally use this 




8.4. Conclusion:  
This study shows the capability of the flower extracts to act as the chemiresistive gas sensors. 
These were the first chemiresistive sensors that are made from renewable source. We also 
demonstrated that these sensor responses were reproducible as the standard deviation values 
were less enough to discriminate between different samples. The sensor fabrication is 
straightforward, easy, does not use hazardous or environment detrimental chemicals and low 
cost. This study shows that these florisensors were reusable and applicable to various real-
time situations where gas sensing is indispensable. This study is a proof of concept 
demonstrating a novel way of volatile sensing by using the flower extracts. The future 
direction is to characterize these sensors, compare them with the existing volatile sensing 
platform regarding sensitivity and other sensor parameters.	We also aim to investigate the 
feasibility of using these florisensor arrays in volatile based disease diagnosis such as cancer, 
tuberculosis, etc. 
8.5. Summary: 
Chemiresistors are the class of sensors widely used in volatile sensing. All the existing 
chemiresistors were expensive or use hazardous chemicals and physical conditions or energy 
inefficient. This study shows the development of a novel class of chemiresistors made from 
flower extracts, thus making these sensors renewable, low-cost and environmentally friendly. 
The chemiresistive abilities of these sensors were demonstrated by discriminating different 
flavors of smoothies and tracing the conversion of milk to yogurt. The spontaneous recovery 
of this sensor without any external stimulus is shown, thus making the sensor reusable. The 
future direction of this study is to increase the number of florisensors by incorporating 
various other flower extracts to increase the dimensionality, thus increasing the resolution of 
these florisensor arrays. The ultimate aim to develop a low-cost, reusable and reliable 




Conclusion and Future Directions 
 
This thesis is a series of comprehensive studies conducted to decipher the non-invasive ways 
of diagnosing cancer. On the course of pursuing these studies, novel methodologies and 
hypothesis were explored such as revealing the volatile signatures of in vitro 3D cancer 
models, cellular level quorum sensing, effect of curcumin treatment on the volatile signature 
of the cancer and non-cancer cells and florisensors – a novel low cost, renewable, reusable 
and eco-friendly chemiresistors for volatile sensing. 
    
This thesis showed that two closely associated cell lines, which were obtained from the same 
donor and differed only in the stages of melanoma could be identified as different cell lines 
by employing 1D 1H NMR spectrometry, which proves the specificity of cell surface 
signatures in characterizing cancer cell lines. This study suggested that the glucose 
accumulation and phospholipid composition vary significantly between the primary and 
metastatic cells lines that were obtained from a single donor and also with the cell culturing 
methods. These results encourage further researches on understanding the effects of 
phospholipid and glucose accumulation in cancer development, progression, and invasion. 
This study also showed that the method of cell culture would drastically affect the 
phospholipid composition of the cells. 
  
Proton NMR markers for differentiating gastric cancer spheroids and normal gastric 
spheroids were deciphered. Eight chemical shift markers that are unique to the gastric cancer 
spheroids were identified. We also demonstrated that 13 markers are significantly lesser in 
the gastric cancer spheroids compared to their normal counterpart. These markers indicate 
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that the cancerous and non-cancerous spheroids differ majorly in the energy metabolism, 
composition of lipid and lipid derivatives. This study opens up avenues for the researches 
focusing on identifying novel lipid targets in gastric cancer. This study also depicts that the 
formation of spontaneous spheroids is not a common trait for all the cell lines. 
The in vitro results suggested the possibility of developing a non-invasive cancer diagnostic 
procedure based on the cancer specific cell-surface signatures using the MRI coupled with 
MRS. As this mode of diagnostic procedure requires a sophisticated and expensive facility, 
this method would not be a right choice to be employed in the developing and under 
developed regions of the world, which suffers high cancer-related mortality. Hence we did 
not proceed with the clinical study and found volatile biomarkers could be the potential 
alternative for developing non-invasive cancer diagnostic procedure.   
Thus, the research focus changed towards identifying VOCs based cancer biomarkers. A 
novel method for the identification of the VOC signature of the cell lines using 3D models 
was shown. The VOC signatures of the 2D models were different from the 3D models. Two 
types of 3D models were developed, and their VOC signatures were evaluated. VOC 
signatures of both the 3D models were very similar, which suggests that direct cell-cell 
contact does not play any role in the VOC signature, providing an insight that these released 
VOCs could function as intercellular signals. As 3D cell culture models are the closest replica 
of the in vivo cells than 2D models, the VOC signature results of the 3D cell culture models 
would be more relevant for the clinical translation of these studies. 
 
The cellular level quorum sensing in a human cell line was explored using the SIFT-MS.  The 
significant product ion M/Z ratios obtained from the statistical analysis of the SIFT–MS data 
at higher cell density is highly significant and consistent. This study suggested the existence 
of the cellular level quorum sensing in the WM266 cells. According to the best of our 
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knowledge, this is the first study to show the existence of cellular level quorum sensing in 
mammalian cells. Histological study to validate the existence of cellular level quorum 
sensing in WM266 is also conducted. A cellular level quorum sensing model and its likely 
role in VOCs based cell signaling were proposed.    
VOCs biomarkers for gastric cancer and effect of the anti-cancer drug curcumin were 
studied. This study used multicellular spheroids to reproduce the in vivo cellular 
microenvironment in vitro as close as possible. Acetaldehyde was found to be a potential 
volatile biomarker for diagnosing metastatic gastric cancer. These results were promising, 
hence translating this study into exhaled breath based gastric cancer detection is possible. All 
the normal gastric spheroids and gastric cancer spheroids studied produced specific volatiles 
in response to the curcumin treatment. Each and every cell line studied gave their unique 
response to the curcumin treatment by expressing unique volatile signatures. Observations on 
acetaldehyde expression by the metastatic gastric cancer spheroids after curcumin treatment 
suggest that these cells respond to curcumin in a dose-dependent manner. These volatile 
signatures would be useful in monitoring the progress of the curcumin treatment against 
cancer. This study was first of its kind, and still, there is a lot of research is yet to be done for 
relating the volatiles represented by the significant M/Z ratios with the established metabolic 
pathways, which would be indispensable in understanding the disease metabolism for the 
better ways of diagnosis and treatment. 
A clinical study where the successful employment of the custom made end-tidal breath 
collection tubes in the gastric cancer biomarker identification from exhaled breath was 
demonstrated. A panel of 19 compounds associated with gastric cancer was discovered, and 
their possible origin was discussed. Previous studies and their conflicts with the current study 
were addressed and explained. The effect of oral hygiene product usage is reflected in this 
study, which suggests that it is better to avoid the oral care products before breath collection. 
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In future, more subjects will be recruited and more gastric cancer associated breath markers 
will be discovered. The future direction of this study will be the validation phase, where the 
results obtained in the discovery phase will be validated. The validation phase will be 
performed by selectively investigating the presence of this identified panel of VOC 
biomarkers in fresh breath samples. This validation study will provide us the specificity and 
sensitivity of the identified panel of VOC biomarkers.  
A novel low-cost, reusable and reliable chemiresistive sensors were required to develop a 
VOCs based cancer diagnosis platform. A study was conducted showing the capability of the 
flower extracts to act as the chemiresistive gas sensors. These were the first chemiresistive 
sensors that are made from renewable source. We also demonstrated that these sensor 
responses were reproducible as the standard deviation values were less enough to 
discriminate between different samples. The sensor fabrication is straightforward, easy, does 
not use hazardous or environment detrimental chemicals and low cost. This study shows that 
these florisensors were reusable and applicable to various real-time situations where gas 
sensing is indispensable. The future direction is to increase the number of florisensors by 
incorporating various other flower extracts to increase the dimensionality, thus increasing the 
resolution of these florisensor arrays. These florisensor arrays may also hold great potential 
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